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ABSTRACT
MECHANISM OF 4-HYDROXYNONENAL INDUCED TOXICITY IN JURKAT
CD4+ T LYMPHOCYTES
Wei-Yuan Chang
April 24, 2006
Oxidative stress-induced immunosuppression could be due to a decrease in
CD4+ T lymphocyte activation or proliferation. 4-Hydroxynonenal (HNE), an end
product of lipid peroxidation, and its protein adducts act as markers of oxidative stress.

In this study, the effects of HNE on a human CD4+ Jurkat T cells were examined.
Systematic determinations of the effects of HNE on cytotoxicity, Akt and protein
phosphatase 2A(PP2A)activation, FaslFasL-mediated apoptotic signaling, methionine
adenosyltransferase (MAT) II activity, MAT 2A and c-Myb expression and cellular
glutathione (GSH) and S-adenosylmethionine (SAMe) levels were performed. The
results showed that HNE induced cytotoxicity, downregulated Akt and upregulated
PP2A activation, and resulted in enhanced FasL expression, death-inducing signaling
complex (DISC) formation, Fas-associated death domain (FADD) recruitment, and
caspases cleavages, and comitantiy decreased c-FLIPs expression. Further, HNEinduced cytotoxicity and lost of survival is associated with GSH depletion in a
threshold phenomena and can be potentiated by inhibition of GSH synthesis. In
addition, HNE toxicity was also involved with SAMe metabolism by inhibition of
MAT II activity, MAT 2A and c-Myb expression and which resulted in decreases in

v

SAMe concentrations and lead to caspase-3 dependent apoptosis. 2(RS)-npropylthiazolidine-4(R)-carboxylic acid (PTCA), a GSH precursor, restored GSH and
SAMe as well as upregulated Akt and MAT activities, protected against HNE toxicity.
It was concluded that HNE toxicity may be due to an Akt regulated, Fas/FasL-

medoated, and caspase-8 dependent apoptotic signaling pathway, that HNE toxicity is
associated with GSH depletion and can be prevented by a GSH precursor, and that
MAT and SAMe may be involved in HNE toxicity.
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CHAPTER I
GERNERALINTRODUCTION

Oxidative stress associated with intracellular cell signaling is an important
pathological factor in several immunosuppressive diseases, such as diabetes mellitus,
chronic hepatis C, chronic alcoholism and AIDS (Smith et aI., 1976; MacGregor, 1986;
Raju et aI., 1994; Sen, 1997; Kajimoto et aI., 2002). The balance of reactive oxygen
species (ROS) and antioxidants regulate both cell activation and cell death in T-cellbased immunodeficiency, allergy, and autoimmune disease by affecting T cell function
and numbers (Serafini, 2000). The goals of this project are to: (1) elucidate the
mechanisms involved in oxidative stress induced suppression of T lymphocytes, and
(2) develop potential therapeutic interventions for oxidative stress related diseases.

Oxidative stress and immune dysfunction
Oxidative stress and disease
Clinically, oxidative stress has been shown to be associated with decreased
immune function in aging and in diseases (Shellito and Olariu, 1998; Calabrese et aI.,
2002). Oxidative stress results in the production ofROS, such as superoxide radicals,
hydroxyl radicals, and hydrogen peroxide (H20 2), and leads to an imbalance of prooxidant-antioxidant status. ROS is known to playa role in chronic inflammation and
human immunodeficiency virus (HI V) infection in immune cells (Cederbaum, 1989;

1

Nakamura et ai., 2002). The association of oxidative stress with HIV infection was
originally implied from the finding of reduced levels of glutathione (GSH) in the
plasma and lymphocytes of AIDS patients (Nakamura et ai., 2002; Shan et ai., 1990).
Alcoholic patients have significantly reduced numbers of CD4+ T lymphocytes in the
periphery and the spleen, as well as a reduction in immune function (Shellito and
Olariu, 1998). In acute or chronic active hepatitis C, oxidative stress increases free
radical generation and membrane lipid peroxidation in the liver and peripheral blood
mononuclear cells (Navas et ai., 1998). These are associated with hepatic damage,
GSH depletion, and increased serum malondialdehyde (MDA) and 4-hydroxynonenal
(HNE) (Esterbauer et aI., 1991). Any process that interferes with the ability ofT cell
division is likely to have major implications for the effectiveness of an immune
response (Hamilos and Wedner, 1985; Droge et ai., 1986).
T cells and immunosuppression
The immune system is generally divided into two categories: innate and
adaptive (acquired) immunity. Adaptive immunity is characterized by the responses of
antigen-specific lymphocytes to antigen. Lymphocytes are critical cellular components
for the adaptive immune response, and regulate both the humoral and cell mediated
immunity, which resist invaders such as viruses that reproduce within the cells of the
body. T lymphocytes are further classified by glycoprotein receptors present on the
cell surface into CD8+ T lymphocytes (also known as cytotoxic/killer T cells) and
CD4+ T lymphocytes (also known as helper T cells). Upon antigen presentation by an
antigen presenting cell (APC), all these cell types act differently to combat the
presented antigen. While stimulation of CD8+ T cells activates them to kill the target
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antigen, stimulation of CD4+ T cells leads to their activation and clonal expansion
(Droge et aI., 1986). CD4+ T lymphocytes are the main regulators of both humoral and
cell-mediated immunity. They mediate the immunogenic response through release of
cytokines signaling other immune cells to kill the target antigen (Brunner et aI., 2003).
Most importantly, the loss of CD4+ T lymphocytes has been clearly related to
impairment of several immune functions and ensuing immunosuppression.
Lipid peroxidation and CD4+ T lymphocyte death
There is increasing evidence that reactive aldehydic molecules generated as a
consequence oflipid peroxidation are causally linked to most of the pathophysiological
effects associated with oxidative stress in cells and tissues (Uchida, 2003). Lipid
hydroperoxides are derived from unsaturated phospholipids, glycolipids, and
cholesterol. They are prominent intermediates of peroxidative reactions induced by
activated species such as hydroxyl radical, lipid oxyl or peroxyl radicals, singlet
oxygen, and peroxynitrite (Fig. 1). Among them, MDA and HNE are clinically and
structurally relevant lipid peroxides (Kalinich et aI., 1999). HNE is considered to be a
physiological messenger molecule signaling for various cellular responses (Uchida,
2003). HNE may playa central role in the down-regulation of cell proliferation and in
the modulation ofT cell differentiation (Liu et aI., 2000). In addition, HNE has been
detected in several oxidative stress related immune diseases including diabetes
mellitus, alcoholism, and atherosclerosis (Romero et aI., 1998). Studies suggest that
the formation of HNE and HNE-protein conjugates is a marker of oxidative stress in
tissues or cells (Kruman et aI., 1997). It was found that after chronic administration of
ethanol to rats for 20 months there were significant increases in free radicals and HNE
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Fig. 1. Structures ofHNE and MDA. Uchida, K. (2003)
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in the hippocampus and cerebellum, which correlated with decreased GSH reductase
activity in these regions (Calabrese et aI., 2002). The results of several clinical studies
suggest that alcoholism, HIV -, and HCV -infected patients were all observed to have
enhanced lipid peroxidation with high plasma MDA and HNE concentrations
(Haughey et aI., 2004; Rigamonti et aI., 2003). Recent findings show HNE induced
apoptotic cell death with concomitantly decreased GSH and glutathione disulfide
(GSSG) in human lymphoma cells (Jurkat) (Liu et aI., 2000). Other results, along with
our studies, suggest that oxidative stress induced by HNE caused T lymphocyte
dysfunction. Hence, it is essential to understand the underlying mechanism involved in
the cytotoxic effects ofHNE on CD4+ T cells.
Fas-mediated cell death
T lymphocyte death is essential for proper function of the immune system.
Under normal physiological as well as pathophysiological conditions, T lymphocytes
undergo activation-induced apoptotic cell death (AICD), which is primarily mediated
by Fas/FasL dependent signaling (Brunner et aI., 2003). Induction of FasL expression
has been implicated in drug and stress induced apoptotic death of T lymphocytes
(Hueber et aI., 2002; Green et aI., 2003). Upon activation, Fas undergoes trimerization
and initiates the formation of the death-inducing signaling complex (DISC) by
recruiting the proapoptotic adapter protein Fas-associated death domain (FADD) and
procaspase-8, also called FADD-like interleukin I

~-converting

enzyme (FLICE)

(Peter and Krammer, 2003) (Fig. 2).
Proteolytic activation ofprocaspase-8 is initiated by its recruitment to the DISC
and triggers a caspase cascade leading to apoptosis (Tibbetts et aI., 2003). FLICE

5

FasL

DISC
Fas
FADD
Procaspase-B
(FLIC

••

Death domain

"
~

Active Caspase-B

!
!

••

Caspase-3
c-FLIPs

DNA Degradation

~

Apoptosis
Fig. 2. Fas-mediated death signaling. Modified from Peter and Krammer (2003).
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inhibitory protein (c-FLIP) is an antiapoptotic cytoplasmic protein with sequence
homology to caspase-8. c-FLIP is unable to undergo cleavage to an active caspase due
to substitution of a tyrosine for an active site cysteine, and hence can function as a
dominant-negative inhibitor of caspase-8, thereby preventing Fas-induced apoptosis
(Hueber et aI., 2002; Green et aI., 2003; Peter and Krammer, 2003). Alternative
splicing yields multiple isoforms of c-FLIP; two commonly occurring isoforms are
designated c-FLIP L (long isoform) and c-FLIPs (short isoform) (Krueger et aI., 2001a;
Tibbetts et aI., 2003). c-FLIP has been shown to play an anti-apoptotic role in a
number of cell types and elevated c-FLIP expression renders cells resistant to Fasinduced apoptosis (Krueger et aI., 2001). In fact, the susceptibility ofT lymphocytes to
Fas-mediated apoptosis correlates with c-FLIP levels, which are elevated during early
stages of activation but are significantly reduced upon re-stimulation when the T cells
undergo AICD (Rigamonti et aI., 2003; Irmler et aI., 1997; Uriarte et aI., 2005). The
molecular mechanisms involved in the regulation of expression of c-FLIP in T
lymphocytes are not completely understood.

Oxidative Stress, GSH and SAMe
GSH, a cysteine-containing tripeptide, plays an important role in the
circumvention of cellular oxidative stress and the maintenance of intracellular thiol
redox status (Khanna et aI., 1998; Sen, 1998; Meister, 1989) (Fig. 3). S-Adenosylmethionine (SAMe) is a major methyl donor for cellular transmethylation reactions
involving proteins, nucleic acids, and various lipids, and it functions as an antioxidant.
SAMe is a GSH synthesis precursor via the transsulfuration pathway and decreases in
SAMe result in GSH deficiency (Honchel et al., 1992). Chronic alcohol abuse not only
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results in hepatic SAMe depletion, but is also associated with a decrease in the levels
of intracellular GSH (Honchel et aI., 1992; Koch et aI., 1991; Wang and Spitzer, 1997;
Shan et aI., 1990). SAMe is also required for cell proliferation upon activation of T
lymphocytes, after which both the SAMe pool size and the rate of SAMe utilization
increase (German et aI., 1983). In Jurkat T cells, GSH content plays an important role
in the cell cycle, rising steadily from the G 1 phase through the S phase, and reaching a
maximum at G2/M (Soderdahl et aI., 2003). Clinically, patients with chronic diseases
such as genitourinary, gastrointestinal, cardiovascular, and musculoskeletal diseases
including cancer had a marked decrease in total GSH content in the blood (Lang et aI,
2000). Oxidative stress diseases and the resultant GSH depletion can adversely affect
normal CD4+ T lymphocyte function, proliferation and survival (Peterson et aI., 1998;
Hamilos and Wedner, 1985; Droge et aI., 1986).
CD4+ T cells are the targets of HIV infection, and the decrease of CD4+ T cells
occurs AIDS. A recovery of the human CD4+ T lymphocyte count was seen in several
studies after supplementation with antioxidant agents, such as N-acetyl-cysteine
(NAC), oxothiazolidine carboxylic acid (OTC), and Vitamin E. This finding indicates
that oxidative stress can affect human CD4+ T lymphocyte survival (Mato et aI., 2002;
Nakamura et aI., 2002). Our preliminary data showed that NAC rescues CD4+ T cells
from H202 induced caspase-3 activation and apoptosis, while depletion of GSH by
buthionine sulfoximine (BSO), which inhibits GSH synthesis, exacerbates it. 2(RS)-nPropylthiazolidine-4(R)-carboxylic acid (PTCA) is a sulfhydryl-protected compound
containing a cyclized form ofL-cysteine (Cys) that can be non-enzymatically
converted to Cys at physiological pH and room temperature (Nagasawa et aI., 1984)
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(Fig. 3). PTCA has been shown to attenuate acetaminophen (APAP)- and paraaminophenol (PAP)-induced hepatic GSH depletion both in mice (Srinivasan et aI.,
2001) and hamsters (Fu, 2001). Whether PTCA can protect against HNE-induced
cytotoxicity and depletion of GSH and SAMe has not been investigated. Thus, our aim
is to investigate the role of antioxidants in HNE-induced cytotoxicity in human CD4+ T
cell immunotoxicity. Further, we plan to explore whether PTCA, a GSH precursor, can
attenuate HNE-induced decreases in intracellular GSH and SAMe, and thereby prevent
its cytotoxicity.
SAMe and MAT II

SAMe also participates in polyamine biosynthesis and is a precursor for the
synthesis of GSH through its conversion to Cys via the transsulfuration pathway. As
vital as GSH is in alleviating endogenous oxidative stress and in functioning as an
antioxidant, SAMe is known to be absolutely critical for T lymphocytes (German et aI.,
1983). Methionine adenosyltransferase (MAT, also know as S-adenosyl-L-methionine
synthetase) is the enzyme that catalyzes the formation of SAMe from methionine and
adenosine triphosphate (ATP) (Cantoni, 1953) (Fig. 4). In mammals, there are two
genes coding for MAT: MATI A and MAT 2A, and their products are know as MAT
IIIII and MAT II, respectively (Cantoni, 1953; Lu, 2000). In lurkat T cells, the MAT
2A gene is highly expressed. Recently, lani et al. in this laboratory have shown that
inhibition of MAT II activity by cycloleucine leads to a decrease of intracellular SAMe
levels in lurkat T cells and loss of survival in MOLT -4 and lurkat T cells. Studies
have shown that T cell activation is associated with increased MAT II expression, and
the turnover of SAMe in activated lymphocytes is five times greater than other extra-
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hepatic tissues, suggesting that MAT II and SAMe play important roles in T cell
activation and survival (German et aI., 1983). Since SAMe deficiency often leads to
GSH depletion via the transsulfuration pathway, more studies suggest that intracellular
GSH or the GSH/GSSG ratio may play an important role for the integrity and activity
of MAT (Shirota et aI., 2002). However, the mechanisms involved in the regulation of
MAT II activity are not completely understood.
Decreased MAT activity and expression are found in alcoholic liver disorders
and viral induced cirrhosis, coinciding with SAMe depletion in both patients and
animal models (Mato et aI., 2002). It was also shown that administration of BSO, an
inhibitor of the GSH biosynthesis, leads to a decrease of MAT activity and SAMe in
rats (Corrales et aI., 1991). Recently, studies demonstrated APAP administration
rapidly depletes hepatic GSH followed by decreases in MAT activity in mice (Shirota
et aI., 2002). Similarly, carbon tetrachloride, galactosamine, and hypoxia decrease
MAT activity in vivo as well (Corrales et aI., 1992; Mato et aI., 1997). These results
have led us to propose that there is a casual relationship between oxidative stress,
decreased levels of antioxidants, and inhibition of MAT activity (Fig. 5). However,
whether MAT is compromised in HNE-induced cytotoxicity in CD4+ T lymphocytes is
not known.
Role of c-Myb

c-Myb is a 75- to 80-kDa protein and is one of the three mammalian Myb
proteins (A, B and C), all of which function as transcriptional factors that are
implicated in the regulation of proliferation, differentiation and apoptosis (Oh and
Reddy, 1999). c-Myb is a transcriptional activator of MAT 2A. In the context of MAT
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2A gene induction, c-Myb expression is induced upon T cell activation and transactivates the MAT 2A promoter by binding to the consensus c-Myb binding site
located at -350 to -333 (Zeng et aI., 2001). c-Myb anti-sense oligonucleotide mediated
inhibition of c-Myb prior to mitogen or antigen dependent stimulation, inhibits T cell
proliferation, suggesting an essential role for c-Myb in T cell expansion (Venturelli et
aI., 1990; Furukawa et aI., 1990). Studies have shown that c-Myb activity is required
for Akt to act as a survival factor during T cell activation and that the c-Myb gene is
only regulated by the components of the PI3K pathway (Lauder et aI., 2001). Although
the effects of c-Myb are well studied in hematopoiesis, the regulation of c-Myb is not
completely understood.
Mediators of the survival pathway
Role of Akt
The survival signal elicited by Akt, a serine/threonine protein kinase, proceeds through
several mechanisms, including inactivation of BAD (Datta et aI., 1997; del Peso et aI.,
1997), which is a death enhancer, and caspase-9 (Cardone et aI., 1998), stimulation of
NF-KB activity, inactivation of the forkhead transcription factor (Kops and Burgering,
1999), and phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) and
glycogen synthase kinase 3 (GSK3) (Cross et aI., 1999). In contrast to the activation of
Akt, associated with its phosphorylation by 3' -phosphoinositide-dependent kinase-1
(PDK1) (Ouyang et aI., 1999), downregulation of Akt is still not fully understood.
Apoptosis is a programmed cell death distinct from necrosis and is under the control of
caspases, a class of cysteine proteases (Cardone et aI., 1998). The putative role of
apoptotic proteases in the degradation of Akt is less defined, but Akt appears to be a
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substrate of caspase-3 in vitro, and caspase-3-dependent cleavage of Akt may be
relevant in detachment-induced and FasL-mediated cell death (Liu et aI., 2000).
Survival factors were equally important in the regulation of the apoptotic process
(Uriarte et aI., 2005). Studies have demonstrated that the PI3KJAkt pathway prevents
the accumulation of intracellular ROS by regulating the expression of the antioxidant
enzyme heme oxygenase (HO-I) in dopaminergic PC12 cells (Salinas et aI., 2003). It
has also been shown that the PI3KJAkt pathway is indispensable for the survival of
human CD4+ T lymphocytes (Salinas et aI., 2003). Studies have demonstrated that Akt
was significantly inactivated and down-regulated in H 20 2-induced CD4+ T cell
apoptosis (Khanna et aI., 1998). However, little is known about the mechanism(s)
employed by the apoptotic machinery to down-regulate Akt survival signals.
Therefore, we used HNE as an oxidative stimulus to examine the role that Akt kinase
plays in lurakt T cell survival during oxidative stress. Another aim ofthis project was
to determine whether there is a direct link between the antioxidants GSH and SAMe
and the regulation of survival factor (Akt). In addition, we investigated the possible
protective effect of increasing GSH concentrations with PTCA on Akt inactivation.
Akt and PP2A
Protein phosphatase-2A (PP2A) is one of four major cytoplasmic
serine/threonine phosphatases that are known to play an important role in the regulation
of diverse cellular proteins, including metabolic enzymes, hormone receptors, kinase
cascades, and cell growth. PP2A is a heterotrimer consisting of a catalytic subunit "C"
(36 kDa), a regulatory subunit "A" (60-kDa) and one of several "B" subunits (54,
55, 72, and 130 kDa) (Ivaska, et aI., 2002; Van Kanegan et al., 2005). The physiologic
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importance of these forms and their regulation by hormones or extracellular stimuli has
not been established. In vitro studies indicate that the catalytic subunit ofPP2A is
regulated by a variety of post-translational modifications, including phosphorylation
(Chen et al., 1992) and methylation. PP2A has been shown to be the major
phosphatase targeting and inactivating Akt in vitro (Van Kanegan et al., 2005), and
several reports have documented the complex formation between these two enzymes
(Ivaska et aI, 2002; Resjo et al., 2002). A PP2A inhibitor, okadaic acid, has been found
to activate Akt in lurkat T cells treated with HNE, suggesting that PP2A is a major
antagonist ofPDK1 in the downregulation of Akt (Liu et al., 2003). It is likely that
Akt modulation involves direct dephosphorylation of Akt activity by PP2A (Fig. 6);
however, the mechanism is not clear. An aim of this project was to investigate the
mechanism.

Akt and c-FLIP s
Although several anti-apoptotic functions of Akt have been identified in T
lymphocytes, the potential role of Akt in regulating c-FLIP expression and the impact
on subsequent apoptotic signaling has not been examined. Through sensitizing Fasmediated death signals, the Akt activation was reported to promote c-FLIP expression
in endothelial cells (Suhara et ai., 2002, 2004) (Fig. 7). c-FLIP expression has been
shown to regulate Fas-mediated apoptosis of activated T cells through competing with
caspase-8 for recruiting to the DISC (Krueger et al., 2001a; Irmler et al., 1997).
Studies have shown that inhibition of Akt, using either a PI3 kinase inhibitor or a
selective Akt inhibitor, up-regulates FasL gene expression, and downregulates c-FLIP

16

T Cell ..... Qr·Qnt"r

Extracellular

r
~

Intracellular

p:~,4~~P2
PI-3,4-P,

PI-3 ,4, 5-P,

~ - - - - - /PP2A/
,

"

~au

~

NFKB

Cell Survival
Fig. 6. Proposed effects ofHNE on Akt and PP2A in regulation of survival signaling.
Modified from Bauer and Baier (2001).

17

•
DISC

... ~~

FasL

••••••••
•••

•••
•••••• Procaspase-B
(FLICE
•••

FADD

0

,

••••

(]

~

•

Death domain

•
••

Active Caspase-B

!
!

Caspase-3

c-FLIPs

DNA Degradation

~

Apoptosis
Fig. 7. Proposed roles of Akt and c-FLIPs in Fas-mediated death signaling. Modified
from Peter and Krammer (2003).

18

expression (Uriarte et aI., 2005). However, regulation of c-FLIP expression in T cells
induced by HNE is not completely understood.
Based on these findings, our working hypothesis is that HNE is involved in
chronic disease induced oxidative damage in CD4+ T lymphocyte. We further propose
that HNE, as well as oxidative stress, involves depletion of cellular GSH and SAMe,
and that downregulation of Akt kinase and MAT II activity leading to an enhanced
susceptibility of CD4+ T lymphocytes to Fas-mediated apoptotic death. The overall
objectives of this proposal are to (1) elucidate the cellular and molecular mechanism(s)
involved in HNE-induced CD4+ T cell depletion and (2) develop possible therapeutic
interventions for preventing CD4+ T cell depletion and following immunosuppression
in HIV/HCV infected patients. The specific aims of this proposal are:
1. Determine the toxic effects of 4-hydroxynonenal (HNE) on human CD4+ T
lymphoma lurkat cells and its association with immune (dys)regulation.
2. Determine the expression ofFas on Jurkat T lymphocytes exposed to HNE and
correlate Fas expression with increased susceptibility to Fas-mediated signaling
and death.
3. Determine the effects ofHNE on cellular antioxidant status by measuring
cellular GSH and SAMe concentrations.
4. Investigate the role of Akt-mediated apoptosis in HNE-induced cytotoxicity in
Jurkat T cells.
5. Determine whether the overall catalytic activity ofPP2A and the involvement
ofPP2A are upregulated via HNE-mediated decreases of Akt activation in
Jurkat T cells.
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6. Determine the effect ofHNE on lurkat T lymphocytes MAT II expression and
activity, SAMe concentrations and metabolism and Fas-mediated apoptotic cell
death.
7. Determine the effect ofHNE on c-Myb, the transtription activator of MAT 2A,
expression in lurkat T cells.
8. Evaluate the efficacy of GSH enhancing precursors against HNE-induced
cytotoxicity and apoptosis in lurkat T cells by preventingp-Akt and c-FLIP s
expressIOn.
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CHPATERII
HNE-INDUCED CYTOTOXICITY IN CD4+ T LYMPHOCYTES

INTRODUCTION
The studies of HNE toxicity in human CD4+ T lymphocytes described in this
chapter were designed to test cellular and molecular mechanisms involved in HNEinduced T cell death. The effect of HNE on cytotoxicity was studied and the
involvement of Fas-FasL mediated apoptotic death was further evaluated. Necrosis
was assessed by elevations in LDH activity and trypan blue count and apoptosis was
assessed by an increase in DNA fragmentation. To evaluate the involvement of Akt, a
survival factor, in apoptotic cell death, the effects of HNE on Akt kinase activation
were examined. To evaluate the involvement of FasL in apoptotic cell death, the
effects of HNE on FasL expression, FADD recruitment and DISC formation were
examined. To evaluate the involvement of caspase in apoptosis, the effects of HNE on
caspase-8 activity, procaspase-8 cleavage and its dependent apoptosis were examined.
Finally, to evaluate the role of anti-apoptotic factors in apoptosis, the effect of HNE on
the expression of c-FLIPs was examined. While the main focus of the study was HNE,
the effect of MDA, the clinically relevant lipid peroxidation end product, was also
examined.
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MATERIALS AND METHODS
Cell culture
Jurkat, clone E6-1, a human CD4+ T cell leukemia cell line, was obtained from
ATCC (American Type Culture Collection, Rockville, MD). Jurkat cells were grown
in RPMI 1640 supplemented with 10% fetal bovine serum, 10 Vlml penicillin, and 10
f,lg/ml streptomycin in a 37°C 5% CO2 incubator. Jurkat cells were resuspended at 1 x

106 cells/ml during treatment.

Chemicals
HNE and MDA were kindly provided by Dr. Sanjay Srivastava, Department of
Internal Medicine. HNE was synthesized as its dimethylacetal starting from
dimethyl acetal of fumaraldehyde as described previously (Chandra et aI., 2004).
Phytohemoagglutinin (PHA), Nonidet P-40, sodium orthovanadate, sodium
pyrophosphate, N,N-dimethylformamide (DMF), sodium dodecyl sulfate (SDS),
aprotinin, leupeptin, benzamidine, and potassium fluoride were purchased from Sigma
Chemical Co. (St. Louis, MO). FADD was purchased from Cell Signaling (Beverly,
CA). Protein AlG agarose and antibodies Fas (B-lO), Fas-L (C-178) and p-Actin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-FLIPy/8 (191-209)
antibody and caspase-8 inhibitor II were purchased from Calbiochem (La Jolla, CA).
Phospho-Akt (Ser 473), total Akt antibodies were purchased from Cell Signaling
(Beverly, CA). Goat anti-rabbitlanti-mouse/anti-rat antibodies conjugated with horseradish peroxidase, which were used as secondary antibodies in immunoblotting, were
purchased from Bioscience International (Rockville, MD). RPMI 1640 dry powdered
medium was pursued from HyClone Co. (Logan, VT). Fetal bovine serum,
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penicillinistI1eptomycin, and trypan blue were purchased from Invitrogen Co. (Grand
Island, NY). Phenylmethylsulfonyl fluoride (PMSF) was obtained from Boehringer
Mannheim Co. (Indianapolis, IN). p-Glycerophosphate was purchased from TCI
America (Portland, OR). Phosphate buffered saline (PBS) was obtained from BD
Biosciences Pharmigen (San Diego, CA).

DNA fragmentation ELISA assay
To measure cell apoptosis, the treated Jurkat T cells were lysed after HNE
treatment for 6 h. DNA fragmentation was quantified using the Cell Death ELISA kit
(Roche, Indianapolis, IN). The assay was based on the quantitative sandwich-enzymeimmunoassay principle using mouse monoclonal antibodies directed against DNA and
histones to determine the presence of mono-and oligonucleosomes in the cytoplasmic
fraction of cttlllysates. The lysate was centrifuged at 200 x g for 10 min and 20 [!l of
the cytoplasmic fraction was transferred to the streptavidin coated micro titer plate. A
mixture of arn.ti-histone-biotin labeled antibody and anti-DNA peroxidase conjugated
antibody was added and the plate incubated for 2 h. After removal of the antibodies by
a washing step, the amount of nucleosome-bound fragmented DNA was quantified
photometrically by the peroxidase retained in the immunocomplex, using ABTS (9,2,
2' -Azino-di [3-ethylbenzthiazolin-sulfonate]) as a substrate. The results were obtained
as optical density values and expressed as fold over untreated cells.

Akt [pS473] ELISA assay
Treated Jurkat T cells were lysed at 0.5 to 6 h for determination of Akt. The
concentrati01l1 of Akt which was phosphorylated at serine residue 473 was determined
by ELISA (Akt [pS473] kit; BioSource International Inc., Camarillo, CA). A
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monoclonal antibody specific for Akt has been coated onto the wells of the microtiter
strips, standards, samples or positive controls were added to appropriate wells and the
plate was incubated for 2 h. After washing, a rabbit antibody, specific for Akt
phosphorylated at serine 473, was added to the wells and incubated for 1 h followed by
the addition of a horseradish peroxidase-labeled anti-rabbit IgG (anti-rabbit IgG-HRP)
working solution to conjugate the antibody for 30 min. After a third incubation and
washing to remove all the excess anti-rabbit IgG-HRP, 100 /-ll of substrate solution was
added, which. was acted upon by the bound enzyme to produce color. After 20 to 25
min, 100 /-ll 0f stop solution was added and the absorbance was measured at 450 nm.
The absorbance of the standards was plotted against concentration. The Akt [pS473]
concentration for unknown samples and controls were calculated from the standard
curve.
PP2A enzymatic activity assay

PP2A enzymatic activity was assessed following PP2A immunoprecipitation
using a malachite green based phosphatase assay (PP2A Immunoprecipitation
Phosphatase Assay Kit; Upstate). Following HNE treatment, cells were lysed with
phosphatase extraction buffer (20mM imidazole-HCI, 2mM EDTA, 2mM EGTA, pH
7.0 with 10 I-Lg/ml each of aprotinin, leupeptin, antipain, soybean trypsin inhibitor, 1
mM phenylIl1lethylsulfonyl fluoride (PMSF), and 1 mM benzamidine) and the lysate
(450 /-lg of protein/per sample) was incubated with 4 /-lg of an anti-PP2A antibody
(clone ID6; Upstate) and 35 /-ll of protein A agarose slurry at 4°C with constant
rocking for 2 h. Agarose-bound immune complexes were collected and, following
washing three times with 700 /-ll TBS and 500 /-ll optimized Ser/Thr buffer (final wash),
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were resuspended in 20 !J,l Serffhr buffer. Phosphopeptide (amino acid sequence: KR-pT-I-R-R) was added (60 I. d) as a substrate for PP2A, and samples were incubated at
30°C in a shaking incubator for 10 minutes. Supernatants (25 !J,l) were transferred to a
96-well platte, and released phosphate was measured by adding 100 !J,l malachite green
phosphate detection solution. Color developed for 15 minutes before reading the plate
at 650 nm. The absorbance of the reactions was corrected by subtracting the
absorbance of blank (25 )..11 Serffhr buffer). Phosphate concentrations were calculated
from a standard curve created using serial dilutions of a standard phosphate solution (0
to 2,000 pm<Dl). Data were normalized to protein concentration and PP2A activity
expressed as pmol phosphate/ )..1g protein/1 0 min.

Caspase-8 activity assay
To measure caspase-8 activity, cytoplasmic extracts were prepared from lurkat
cells treated for 6 h, and analyzed using the CASPASE-8 Colorimetric Activity Assay
kit (Chemicon International, Temecula, CA). The assay was based on
spectophotometric detection of the chromophore p-nitroaniline (pNA) after cleavage
from the caspase-8 specific substrate IETD-pNA. The free pNA was quantified using a
microtiter plate reader at 405 nm. In brief, cell lysate was centrifuged at 10,000 x g for
5 min and 45 !J,l of the cytoplasmic fraction was transferred to a fresh tube and put on
ice. A mixture of assay buffer (5X), sample supernatant, caspase-8 substrate and
distilled water were added and the plate incubated for 2 h. Read samples at 405 nm
with a microtiter plate reader. The optical density values obtained with the CASPASE8 Colorimetric Activity Assay kit for unknown samples were calculated from the
standard curve. Comparison of the absorbance of pNA from an apoptotic sample with
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an untreated control allows determination of the fold increase in caspase-8 activity.
The definition of one unit is the amount of enzyme that will cleave 1.0 nmol of the
colorimetric substrate Ac-IETD- pNA per hour at 37°C under saturated substrate
concentrations. The results were expressed as activity units per mg of protein.

RNA isolation and real time peR analysis
Reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to
assess FasL mRNA levels in Jurkat cells. Total RNA was isolated from treated cells
after 1 h, using TRIZOL (Invitrogen, Carlsbad, CA). For real time PCR, the first
strand cDNA was synthesized using TaqMan Reverse transcription reagents (Applied
Biosystems). The reverse transcription was carried out using IX Taqman RT buffer,
5.5 rnM MgCh, 500 /-lM of each dNTP, 2.5 /-lM random hexamer, 8 U of RNase
inhibitor and 25 U of Multiscribe Reverse Transcriptase with 200 ng of total RNA.
The RT conditions were 10 min at 25°C, 30 min at 48°C and 5 min at 95°C. Reactions
in which the enzyme or RNA were omitted were used as negative controls. Real time
PCR was peliformed with an ABI prism 7000 sequence detection system and SYBR
green I dye reagents. The specific primers were designed for human GAPDH and FasL
using the Primer3 software program. The following primers were used in real time
PCR:
hGAPDH-RT-FPl:

5' TGGGCTACACTGAGCACCAG 3'

hGAPDH-RT-RPl:

5' GGGTGTCGCTGTTGAAGTCA 3'

hFasL-RT-FP:

5' GGCCTGTGTCTCCTTGTGAT 3'

hFasL-RT-RP:

5' TGCCAGCTCCTTCTGTAGGT 3'

hFasR-RT-FP:

5' TTG CTA GAT TAT CGT CCA AAA GTG TT 3'
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hFasR-RT-RP:

5' AAC AGT CTT CCT CAA TTC CAA TCC 3'

The ]parameter Ct (threshold cycle) was defined as the fraction cycle number at
which the fhwrescence passed the threshold. The relative gene expression of FasL was
analyzed using T

MCt

method (Livak and Schmittgen, 2001) by normalizing with

GAPDH gene expression in all the experiments.
Trypan blue dye exclusion

To measure viability, cells were stained with trypan blue dye and then counted
by light microscopy with a minimum of 100 total cells counted per slide, and scored as
cells which were able to exclude the dye (alive) or unable to exclude the dye (dead).
The results were expressed as the percentage of untreated cells (McClowskey et aI.,
1998).
ImmunoprelCipitation and western blot analysis

For immunoprecipitation (IP) of the Fas DISC, 20 x 106 lurkat T cells were
untreated or treated with HNE 2.5, 5 or 10 [.tM for 3 h. Following treatment, cells were
lysed with IP lysis buffer (PBS pH 7.4, 1% NP-40, 200
mg/ml PMSF, 10

~g/ml

aprotinin, 10

~g/mlleupeptin,

~M

4

sodium orthovanadate, 0.1

~g/ml

benzamidine, 50 mM

potassium fluoride, 1 mM p-glycerophosphate, 5 mM sodium pyrophosphate, 1 ~M
okadaic acid) and the lysate (300 [.tg of protein/per sample) was incubated with 0.4 [.tg
of anti-Fas (113-10) antibody with overnight rotation at 4°C. The following day, 20 [.tl of
protein A/G plus agarose was added for 2 h rotation at 4°C and then
immunoprecipitates were washed four times with IP lysis buffer, then separated on a
10% SDS-PAGE and subjected to standard immunoblotting with an anti-FADD and
anti-caspase-8 antibody.
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Following treatment, cells were lysed and total cellular proteins (55-65 !lg of
protein) were resolved on a 10 % SDS-PAGE and subjected to standard
immunoblotting procedures. The primary antibodies used in this study were as
follows: anti-FasL (C-178) 1:750; anti-FADD 1:1000; anti-caspase-8 1:100; antiFLIPy/8 1:750 and f3-Actin 1:1000. The appropriate secondary antibodies were used at
1:2000 for FasL and FADD; 1:5000 for FLIPy/8 and f3-Actin and 1: 15,000 for caspase8. Proteins signals were visualized using the ECL system (Amersham Pharmacia
Biotech, Piscataway, Nl), as directed by the manufacturer. The molecular sizes of the
developed proteins were estimated by comparison with prestained protein markers
(Invitrogen, Carlsbad, CA).

Statistical analysis
Data are expressed as means ± SD. Statistical analyses were performed using
SPSS 11.5 (SPSS Ins., Chicago, IL) for Windows XP. Differences between the means
of two groups were evaluated by a two-tailed t -test for independent samples.
Differences between the means of three or four groups were evaluated by a single
factor analysis of variance (ANOV A), and further assessed by Tukey tests. Differences
were considered statistically significant for P < 0.05.

RESULTS
Effect of HNE and MDA on cell viability
Our previous studies have shown that HNE leads to a significant loss in
survival due to the induction of apoptotic death. Treatment of lurkat T cells with HNE
significantly decreased survival to 32% (at 2.5 ).lM) and 22% (at 5 ).lM), respectively,
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Fig. 8. Effects of HNE and MDA on cell viability. Cells were maintained in low serum
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(B) for 24 h. Cell survival was measured by Trypan blue exclusion assay. Data were
normalized to the untreated control (which is set to 100%) and represented as mean ± SD
of three separate experiments. *P<0.05 compared to UT .
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of the untreated value (Fig. 8A). HNE also induced a dose dependent increase (2 to 2.5
fold) in the DNA fragmentation in correspondence with the observed loss of T cell
survival (data not shown).
Since HNE had a significant effect on T cell survival, we further examined the
effect of another lipid peroxidation product, MDA (2.5 and 5

~M).

In contrast to HNE,

treatment of lurkat T cells with increasing concentrations of MDA had no effect on the
T cell survival; the cell viabilities were 90 ± 0.05% and 85 ± 0.08% of untreated
control at 2.5 and 5

~M,

respectively (Fig. 8B).

Effects of HNE on Akt kinase
The serine-threonine kinase (PKB/Akt) has been shown to be critical for T
lymphocyte survival and inhibition of Akt leads to apoptotic T cell death. To further
investigate the mechanism of HNE-induced apoptotic cell death, we studied the role of
Akt kinase in the survival pathway. In untreated cells, Akt was found to be
constitutively phosphorylated at Ser 473. The basal level of p-Akt in untreated cells
was 28.61 ± 2.04 unit/mg protein. Cells were exposed to different concentrations of
HNE 2.5, 5, and 10 ~M for 6 h. The resulting p-Akt concentrations were found to be
20.99 ± 3.13, 3.17 ± 3.28, 1.45 ± 0.06 unit/mg protein, respectively, which were about
37, 11 and 5% of the untreated values (Fig. 9A). The results of decreased phospho-Akt
levels were further confirmed by western blot analysis. A dose-dependent
dephosphorylation of phospho-Akt was observed in cells treated with HNE (2.5-10
/-lM) at 3 h. Similarly, HNE effectively decreased Akt activation at 6 h. The most
profound decrease in dephosphorylation of Akt was found at 10 /-lM HNE. There were
no significant changes in total Akt at 3 h after HNE treatment. However, HNE
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Fig. 9. HNE downregulates Akt activation. Sample preparation was as described in Fig.
8A. (A) p-Akt concentration. Cell extracts were harvested at 6 h after HNE treatment.
Data were normalized to protein concentration and p-Akt concentrations expressed as
unit/mg protein. Data are represented as mean ± SD of three separate experiments.
*P<O.Ol and **P<O.OOl compared to UT. (B) Western blotting. Total celllysates were
collected for Western blot analysis as described in Materials and Methods. Akt and
phospho-Akt were detected at 3 h (left panel) and 6 h (right panel) by immunoblotting
using anti -Akt and phospho-Akt antibodies. Blots were stripped and reprobed with
antibody to ~-actin to ensure equivalent loading. A representative gel out of three
experiments is shown.
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decreased phosphor- and total Akt expression at 6 h with HNE concentrations of 5 and
10 11M (Fig. 9B). Thus, these results demonstrate that in a dose-dependent manner,
HNE mediates the dephosphorylation of Akt in the early stage of apoptosis.

Effects of HNE on PP2A activity
PP2A is serine/threonine phosphatase and studies have shown that PP2A
dephosphorylated and inactivated Akt in vitro (Van Kanegan et aI., 2005). To confirm
the involvement of PP2A in the process of HNE-mediated Akt dephosphorylation, we
next examined whether the overall catalytic activity of PP2A was upregulated after
HNE treatment. Using a nonradioactive serine/threonine phosphatase assay kit with
the phosphopeptide K-R-pT-I-R-R as a substrate, we measured the amount of released
phosphate, which indicates PP2A catalytic activity. In untreated lurkat T cells, PP2A
activity was determined by the phosphate release, which was 137 ± 42 pmol phosphate/
~g

protein! 10 min. As shown in Fig. 10, at 30 min after HNE (2.5 and 5 11M)

treatment, PP2A activities increased 160% (220 ± 43 pmol phosphate/ ~g protein! 10
min) and 212% (290 ± 101 pmol phosphate/ ~g protein! 10 min), respectively, of the
untreated value. Our results suggest that PP2A enzymatic activity is increased dosedependently in lurkat T cells treated with HNE.

Effect of HNE on FasL expression
Since FasL is a well established apoptotic stimulus for T lymphocytes, we
examined FasL expression in the HNE treated lurkat T cells. Immunoblot analysis
showed that treatment of cells with HNE (2.5 and 5 11M) for 6 h significantly increased
FasL protein expression as compared to the untreated cells (Fig. lIA). On the other
hand, corresponding to its minimal effect on cell survival, treatment of cells with MDA

33

C)

*

*

5

10

::t

-s::::
(1).';E
J:o

0.,...

mo.!:

J:(I)

0._0
00.

E

0.

100

0
UT

2.5

HNE(J.1M)

Fig. 10. HNE increases PP2A activity. Sample preparation was as described in Fig. 8A.
Cell extracts were harvested at 30 min after HNE treatment. PP2A activity was measured
using PP2A immunoprecipitation assay kit as described in Materials and Methods. Data
were normalized to protein concentration and PP2A activity expressed as pmol phosphate/ Ilg
protein/lO min. Data are represented as mean ± SD of three separate experiments. ·P<0.05
compared to UT .

34

0.93

1.06

1.09

1.21

0.87

10

UT

0.85

0.70

FasL

/3-Actin

'~::---

UT

.-~' - . -

2.5

5

HNE (IlM)

5

10

MDA (IlM)

w
U>

Fig. 11. HNE enhances FasL expression. (A) Western Blot Analysis: Cells exposed to
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celllysates were collected for Western blot analysis as described in Materials an d Methods.
FasL was detected at 6 h by irnrnunoblot ting using an anti -FasL-specific antibody. Blots
were stripped and reprobed with antibody to ~-actin to ensure equivalent loading. A
representative gel out of three experiments is shown. (B) Real Time PCR: Total RNA was
isolated from cells, untreated (UT) or treated with HNE (2.5 and 5 !-1M) at 1 h. (C) Real
Time PCR: Total RNA was isolated from cells, untreated (UT) or treated with HNE (5 !-1M)
at 1, 3 and 6 h. FasL mRNA levels were determined by real time PCR. Data are represented
as mean ± SD of four separate experiments. ·P<0.05 compared to UT.
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(5 and 10 !lM) at 6 h showed no increase in FasL protein expression (Fig. lIA). To
determine whether the enhancement in the FasL protein in response to HNE treatment
was at the transcriptional level, we quantified the steady state FasL mRNA levels by
real time PCR. Total RNA was isolated from T cells that were exposed to HNE (2.5
and 5 !lM) in serum free medium for 15 min and then serum containing medium for 1 h
and analyzed by real time PCR. The data showed that in correspondence with FasL
protein expression, FasL rnRNA was significantly induced (approximately 2-fold) after
1 h treatment with HNE (Fig. lIB). Total RNA was isolated from T cells exposed to 5
!lM HNE for 1, 3 and 6 h, the time effect analyzed by real time PCR. The data showed
that FasL rnRNA was induced (2 to 4 fold} after HNE treatment in a time-dependent
manner (Fig. 11 C).

Effects of HNE on Fas mediated DISC formation
To further elucidate the effect of HNE, components of the FaslFasL apoptotic
pathway were examined in HNE treated T cells. FasL binding to the Fas receptor (Fas)
is known to induce the formation of DISC, involving the recruitment of FADD and
subsequent recruitment and activation of caspase-8 (Peter and Krammer, 2003).
Hence, the effect of HNE treatment on FADD recruitment to Fas was examined. A Fas
antibody was used to immunoprecipitate the DISC from lysates (normalized for
protein) of cells treated with HNE (2.5, 5 and 10 JlM). Irnmunoprecipitates were
resolved using SDS-PAGE and examined by Western blot analysis using antibodies
against FADD and Fas. Increased recruitment of FADD was seen in HNE treated cells
as compared to the control cells (Fig. 12).
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Fig. 12. HNE increases binding ofFADD to the DISC. Cells were incubated with HNE (2.5,
5, and 10 IlM) for 3 h. Total celllysates were collected for irnrnunoprecipitation with Fas
receptor antibody followed by irnrnunoblotting analysis with FADD or caspase -8 antibodies
as described in Materials and Methods. Untreated cells (UT) were used as a negative control;
blots were stripped and reprobed with Fas receptor antibody (pas B -10) to ensure equivalent
loading. PHA (10 Ilglml) is a positive control. A repres entative gel out of three experiments
is shown.

Further analysis of the immunoprecipitates showed that the increase in FADD
recruitment was accompanied by an increase in procaspase-8 recruitment into the DISC
(Fig. 12). The 56 kDa procaspase-8 undergoes several processing steps to generate
cleaved fragments ofp42-44 kDa, p28 kDa, p18 kDa and pl0-12 kDa in different cells
undergoing apoptosis. HNE was found to significantly increase caspase-8 activation.
This activation was documented by the presence of the p42 kDa cleavage product of
caspase-8 in HNE treated celllysates (Fig. 13).
Effect of HNE on c-FL1Ps expression, caspase-8 activity and DNA fragmentation
To further elucidate the molecular mechanism of Fas-mediated apoptosis in
response to HNE in T lymphocytes, we eX'8lIlined the effect of HNE on expression of
c-FLIPs, since it has been demonstrated that c-FLIPs is a dominant negative inhibitor
of caspase-8. Western analysis was performed on lurkat T cells showed that c-FLIPs
levels decreased after HNE treatment (Fig. 14). Corresponding with the increase in
FasL expression and decrease in c-FLIPs levels, HNE led to a significant dosedependent increase in caspase-8 activity (Fig. 15A). Moreover, pretreatment of lurkat
cells with a caspase-8 specific inhibitor blocked the DNA fragmentation induced by
HNE (Fig. 15B). This data suggests that HNE leads to caspase-8 dependent apoptotic
death was caused by the up-regulation of FasL expression and down-regulation of cFLIPs levels (Figs. 11 and 14).
Relevance of FasL expression to cell death induced by HNE
To test the functional relevance of FasL expression in HNE-induced cell death,
we examined whether the blocking of FaslFasL ligation would protect lurkat T cells
against apoptosis. With this intent, we used the anti-FasL IgG antibody (NOK-2),
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ofHNE (2.5, 5 and 10 [tM) for 6 h. Total celllysates were collected at 6 h for Western blot
analysis as described in Materials and Methods. Untreated cells (UT) were used as a
negative control. Pro and active caspase -8 was detected by inununoblotting using anti caspase-8 antibody. Blots were stripped and reprobed with antibody to ~-actin to ensure
equivalent loading. A representative gel out of three experiments is shown.
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Fig. 14. HNE downregulates c -FLIPs protein. Cells were exposed to different
concentrations of HNE (2.5 ,5 and 10 ILM) for 3 h (left panel) and 6 h (right panel). Total
celllysates were collected for Western blot analysis as described in Materials and Me thods.
c-FLIPs was detected at 3 and 6 h by immunoblotting using anti -c-FLIP8/y antibody. Blots
were stripped and reprobed with antibody to [3-actin to ensure equivalent loading. A
representative gel out of three experiments is shown.

Fig. 15. HNE induces Caspase-8 dependent apoptosis. (A) Cell apoptosis was
measured by caspase-8 activity assay. Cells were exposed to different concentrations
of HNE (2.5, 5 and 10 ~M) and the total celllysates were collected at 6 h after HNE
treatment for caspaspe-8 activity assay as described in Materials and Methods. Data
were expressed as unit per mg of protein and represented as mean ± SD of six separate
experiments. *P<0.05 compared to UT. (B) DNA fragmentation: Cells were
maintained in low serum medium (l %, over night) and then pretreated with 100 ~M of
Caspase-8 inhibitor (CI) for 1 h. After 1 h, cells were treated with increasing
concentrations of HNE (2.5 and 5 ~M) for 8 h. Cell survival was then measured by
DNA fragmentation using the Cell Death ELISA kit. Data were normalized to the
untreated control (which is set to 1) and represented as mean ± SD of three separate
experiments. In each experiment, duplicate wells are assayed separately for each
treatment. *P<0.05 compared to UT, a,b P<0.05 compared to HNE 2.5 and 5 ~M,
respectively.
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Fig. 16. Neutralization of FasL protects Jurkat T cells from apoptosis induced by HNE.
Jurkat T cells were untreated (UT) or treated with HNE (2.5 and 5 ~M). In one group,
NOK-2 antibody (50 Ilglrnl) or the isotype IgG 2a (50 ~glrnl) control was added 15 mi n
after treating the cells with HNE, and then the cells were harvested a t 6 h to measure
apoptosis. Cytoplasmic extracts were prepared and analyzed for DNA fragmentation by
Cell Death ELISA kit as described in Materials and Methods. Data were normalized to
the untreated control and represented as mean ± SD of three different experiments. *p<
0.05 compared to UT, a p< 0.05 compared to HNE 5 ~M.

which recognizes and neutralizes both membrane-bound and soluble forms of FasL in
human by interfering with Fas/FasL ligation and inhibiting Fas signaling. Incubation
of lurkat T cells with NOK-2 antibody after HNE (2.5 and 5 /-LM) treatment for 15 min
attenuated apoptosis by approximately 8 and 24%, respectively. Treatment with the
IgG 2a isotype antibody (negative control) did not protect cells from undergoing
apoptosis (Fig. 16). The results showed the association between HNE and Fasmediated apoptosis, suggesting HNE-induced apoptosis is partly mediated by FasL
expression.

DISCUSSION
During the process of lipid peroxidation, several reactive low-molecular weight
products are formed, including reactive aldehydes, e.g., 4-hydroxynonenal (HNE).
HNE is one of the major aldehydic products of the peroxidation of membrane 0)-6
poly-unsaturated fatty acids. It has been implicated as a causative agent in cytotoxic
processes initiated by the exposure of cellular systems to oxidizing agents (Uchida,
2003; Minotti et aI., 1991; Kalinich et aI., 1999). In comparison to free radicals, the
aldehydes are relatively stable and can diffuse within or be released extra-cellularly and
attack targets distant from the site of the original event. Significantly, HNE functions
as an endogenous lipid mediator to induce a variety of cellular processes that represent
a cellular response program under oxidative stress (Benedetti et aI., 1984). Clinically,
HNE is highly likely to be causally involved in many of the pathophysiological effects
associated with oxidative stress and immune dysfunction such as diabetes mellitus,
alcoholism, and HIV and HCV infection (Clot et aI., 1994; Cambiaggi et aI., 1997;
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Kajimoto et aI., 2002; Rigamonti et aI., 2003). In the context of immune dysfunction,
HNE has been demonstrated to playa critical role in the down-regulation of cell
proliferation and in the modulation of cell differentiation in T lymphocytes (Barrera et
aI., 1991; Gioacchini et aI., 1999). CD4+ T cells are critical regulators of both the
humoral and cell mediated immunity and their loss plays a significant role in immune
dysfunction. Hence, the mechanisms underlying the effect of HNE on CD4+ T cell
survival were examined.
Our earlier results demonstrated that HNE (2.5 and 5 f,lM) induced dosedependant cell death as assessed by trypan blue exclusion and apoptosis as assessed by
DNA fragmentation in lurkat cells (Chang, 2004). Others have also shown that HNE
(20-50 f,lM) induced dose-dependent apoptosis in human lymphoma lurkat T cells.
However, they showed that HNE at 20 f,lM reduced cell viability to approximately 60%
of the untreated cells, whereas at lower concentrations (:s 10 f,lM) HNE had no effect
(Brunner et aI., 2003; Liu et aI., 2000).

However, the difference of the result is

possibly through the source of HNE. Thus, our results along with others confirmed
that HNE can cause cytotoxicity. Further our results showed that MDA, another lipid
peroxidation product, had no effect on cell viability, suggesting that HNE is more toxic
than MDA. Others have shown a similar pattern of toxicity in human fibroblasts when
treated with HNE and MDA (Michiels and Remacle, 1991). HNE is highly reactive
and has three reactive groups (i.e., an aldehyde, a double-bond, and a hydroxy group),
which might possibly explain its higher toxicity through the initiation and propagation
of a free radical chain reaction.
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The serine-threonine kinase Akt (or PKB) is critical for survival and protection
against apoptosis in various cells (Burgering and Coffer, 1995; Franke et aI., 1995).
The balance between survival and apoptosis, specifically in T lymphocytes, is directly
associated with immune function. Up-regulated Akt promotes cell survival by
phosphorylating and thereby inhibiting a variety of downstream key proapoptotic
targets such as GSK-3 (Cross et aI., 1995) and caspase-9 (Cardone et aI., 1998), and by
activating transcriptional factors such as nuclear factor-KB (NFKB) and Forkhead
(Kops and Burgering, 1999) in T lymphocytes. Survival factors are equally important
in the regulation of the apoptotic process induced by oxidative stress. Studies
demonstrated an early increase followed by a significant decrease in phosphorylation
of Akt in methylpyridinium (MPP+)-induced apoptotic death in SH-SY5Y
neuroblastoma cells (Halvorsen et aI., 2002). Others reported that excessive damage
can increase dephosphorylation of Akt without a transient increase in Akt
phosphorylation after focal cerebral ischemia in mice (Noshita et aI., 2001). Our
results did not show that an early increase of Akt phosphorylation after HNE treatment
could be due to HNE, a potent reactive oxidant which caused excessive damage in
lurkat T cells. These findings support the PI3-kinase pathway as being predominantly
anti-apoptotic, and together, suggest that prevention of Akt shutdown or increasing Akt
activation may block apoptosis.
Our results showed that p-Akt concentration in untreated lurkat was about 30 unit
per mg protein and constitutively activated and that HNE downregulated Akt activation
(Fig. 9). Others have shown that 20 IlM HNE-induced dephosphorylation of Akt at
Ser473 in lurkat cells (Liu et aI., 2003). In comparison, we found that Akt inactivation
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occurred at much lower concentrations of HNE (2.5-10 /lM). This finding is relevant to
pathophysiological conditions, since HNE at these concentrations was found to alter cell
signaling, and to cause DNA damage, cytotoxicity, and apoptosis.
Similar results from other oxidative stimuli such as H202 on Akt activity were
observed. We found that when lurkat T cells were exposed to H 20 2 (100-500 /lM), there
was a downregulation of Akt activation as assessed by Western blot analysis (data not
shown). Others demonstrated that phospho-Akt expression was decreased in neonatal rat
ventricular myocytes exposed to H 20 2 for 15 min (Jamnicki-Abegg et aI., 2005). In
addition, decreases in both activating phosphorylation of Akt and total Akt in H20 2induced apoptotic death were observed in cardiac H9c2 cells (Murata et aI., 2003).
Treatment of human embryonic kidney cells with H 202 decreased Akt activities and
increased apoptosis as indexed by cell shrinkage and DNA fragmentation (Shaw et aI.,
1998). Furthermore, treatment with a PI3K1Akt inhibitor (LY294002) resulted in Akt
inactivation and apoptosis in mouse fibroblast and human leukemia cell lines (Uriarte et
aI.,2005). Thus, results from our findings and from others clearly demonstrate that HNE
and other oxidative stimuli induced apoptotic cell death in T lymphocytes, and were
closely related to the downregulation of Akt activity.
In mammalian cells, protein phosphorylation and dephosphorylation involved in
distinct survival signaling pathways plays an important role in apoptosis. PP2A is the
most abundant serine/threonine-specific phosphatase and plays a role in multiple cellular
functions such as cell division, signal transduction, and development (Chen et aI., 1992).
PP2A plays a critical role in Akt inactivation, for it dephosphorylates two
phosphorylation sites (Ser473 and Thr308) of Akt and forms a complex with Akt (Ivaska
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et aI, 2002; Resjo et aI., 2002). In this study, we showed that HNE increased PP2A
catalytic activity (Fig. 10), and concomitantly downregulating Akt (Fig. 9). Others have
also demonstrated that HNE increased PP2A activity, and pretreatment of Jurkat T cells
with a PP2A inhibitor, okadaic acid, prevented this increase (Liu et aI., 2003). H202 has
been shown to increase apoptosis and the dephosphorylation of Akt by increasing
interaction between PP2A and Akt in H9c2 cells. But, no direct increases of PP2A
activity were observed (Murata et aI., 2003). The involvement of PP2A is not
completely understood. Recent studies have shown that TNF-induced endothelial
apoptosis involves the activation of Bad via PP2A-dependent inhibition of MEK
phosphorylation (Grethe and Pron-Ares, 2006). Together, these studies suggest that
phosphorylation and dephosphorylation plays an important role in regulating HNE
mediated cellular processes such as survival and apoptosis by Akt kinases and PP2A.
FasL expression plays a major role in the AICD of activated mature T cells and T
cell hybridomas (Martinez-Lorenzo et aI., 1998). Exposure of CD4+ T cells (Jurkat) to
HNE led to an up-regulation in FasL mRNA and protein (Fig. 11). Apoptosis induced by
HNE was blocked by incubation with FasL neutralizing antibody, demonstrating the
functional relevance of FasL expression in T cells exposed to lipid peroxides. Although
neutralization of FasL significantly protected T cells from undergoing apoptosis, the
NOK-2 antibody did not completely abrogate DNA fragmentation (Fig. 12). This finding
suggests the possible involvement of both Fas-dependent and Fas-independent pathways
leading to T cell death under these conditions.
Activation of Fas by FasL leads to its trimerization and recruitment of the
adaptor molecule FADD and procaspase 8, forming DISC (Chinnaiyan. et aI., 1995;
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Schraven and Peter, 1995; Uriarte et aI., 2005). Our data show that exposure ofT cells
to HNE induces FasL expression leading to Fas-FasL-dependent clustering of Fas and
formation of DISC involving recruitment of FADD and procaspase-8 (Fig. 13). Also,
the presence of cleaved caspase-8 together with FADD and procaspase-8 in the DISC
assembly (Fig. 14) showed that caspase-8 is activated at the DISC (Medema et aI.,
1997). Moreover, HNE treatment enhanced the recruitment ofFADD and procaspase8 in a dose-dependent manner, suggesting that the enhancement in DISC formation
corresponds with the levels of HNE or degree of lipid peroxidation experienced by the
T lymphocytes. Apoptosis of activated T cells mediated by Fas has been shown to be
regulated by c-FLIP expression (Krueger et aI., 2001). There are two isoforms of cFLIP, c-FLIPs and c-FLIPL, both of which can be recruited to the DISC (Krueger et
aI., 2001a; Tibbetts et aI., 2003). Although the role of c-FLIPL is controversial, in T
cells c-FLIPs was shown to be antiapoptotic and to confer resistance to Fas-mediated
apoptosis by blocking proteolytic activation of caspase-8 at the DISC (Krueger et
aI., 2001, 2001a; Irmler et aI., 1997). Our study showed that HNE treatment
downregulates c-FLIPs expression, implicating c-FLIPs as an important regulator of
HNE-mediated apoptosis in T cells (Fig. 15).
In HNE treated cells the resultant increase in FasL expression, DISC assembly
and caspase-8 activation was accompanied by DNA fragmentation. Others have shown
that HNE induces a cellular redox status related to the activation of caspases, including
caspase-8, -9 and -3 and induction of apoptotic cell death in Jurkat T lymphocytes (Liu
et aI., 2000). Our findings further extend these observations and identify the formation
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of DISC leading to increased caspase-8 activation as the critical initiator of apoptotic
death induced in T lymphocytes by HNE.
In conclusion, we showed that HNE induced significant loss of survival due to
enhanced FasL expression, in turn, leading to the induction of the DISC and a
corresponding decrease in c-FLIPs protein and caspase-8 activation. These data
identify a pathogenic molecular mechanism(s) induced by HNE in CD4+ T cells and is
consistent with a potential role of lipid peroxidation-derived products in programmed
cell death. Importantly, this work has begun to elucidate the potential role of lipid
peroxidation products, in particular HNE, in the pathogenesis of immunosuppressive
disorders involving CD4+ T cell depletion such as HIV and HCV infection, and this
work can lead to the development of much needed anti-oxidant therapies.

51

CHPATERIII
ROLE OF GSH AND PTCA PROTECTION IN HNE-INDUCED
CYTOTOXICITY

INTRODUCTION
The studies on HNE toxicity in human CD4+ T lymphocytes described in this
chapter were design to test the protective role of PTCA in HNE-induced T cell death.
The effect of PTCA on HNE-induced cytotoxicity was studied and the role of GSH and
Akt kinase and Fas-mediated death signaling were further evaluated. Cytotoxicity was
assessed as described in Chapter II. To evaluate the role of GSH in toxicity, the effects
of HNE on GSH concentrations and the ability of GSH precursor PTCA to protect
against HNE toxicity were determined. To evaluate the role of Akt kinase in toxicity,
the effects of PTCA on HNE-induced Akt downregulation and PP2A activation were
examined. To evaluate the protection of Fas-mediated death signaling, the effects of
PTCA on FasL and c-FLIPs expression of HNE toxicity were examined. Finally, to
evaluate the possibile sensitizating effect of GSH depletion, the effects of BSO, a GSH
biosynthesis inhibitor, on MDA toxicity were examined.

MATERIALS AND METHODS
Cell culture
Jurkat T cells were obtained and prepared as described in Chapter II.
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Chemicals
2(RS)-n-propylthiazolidine-4(R)-carboxylic acids was synthesized and kindly
provided by Dr. Herbert T. Nagasawa (VA Medical Center, Minneapolis, MN). BSO
and MPA were purchased from Sigma Chemical Co. (St. Louis, MO).

Analyses of GSH
Cell pellets were dispersed with 0.25 ml of 4% MPA and centrifuged at 10,000
x g for 2 min. The supernatants were collected for GSH analysis using an HPLC
method with dual electrochemical detection (HPLC-DEC; Richie et aI., 1987; Chen et
aI., 1990). In brief, 20 f!l samples were injected onto a 250 x 4.6 mm, 5 f!m, C-18
column (Val-V-Pak HP, fully endcapped ODS, Chrom Tech Inc., Apple Valley, MN),
eluted isocratically with a mobile phase consisting of 0.1 M monochloroacetic acid, 2
mM heptane sulfonic acid, and 2% acetonitrile at pH 2.8, and delivered at a flow rate

of 1 ml/min. The compounds were detected in the eluant with a Bioanalytical Systems
model LC4B dual electrochemical detector using two Au-Hg electrodes in series with
potentials of -1.00 V and +0.15 V for the upstream and downstream electrodes,
respectively. Current (nA) was measured at the downstream electrode. Analytes were
quantified from peak area measurements using authentic external standards.

Akt [pS473] ELISA assay
lurkat T cells were pretreated with PTCA at 250 f!M for 1 h before the addition
ofHNE at 2.5 or 5 )!M. Samples were collected at 6 h and lysed for determination of
the phosphorylated Akt levels using an Akt [pS473] kit. Method details were
described in Chapter II.

DNA fragmentation ELISA assay
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lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the addition
ofHNE at 2.5 or 5 J..lM. Method details were described in Chapter II.

PP2A enzymatic activity assay
lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the addition
ofHNE at 2.5 or 5 J..lM. PP2A enzymatic activity was assessed following PP2A
immunoprecipitation using a malachite green based phosphatase assay (PP2A
Immunoprecipitation Phosphatase Assay Kit). Method details were described in
Chapter II.

Western blot analysis
6

15 x 10 lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the
addition of HNE at 2.5, 5, or 10 !AM for 3 and/or 6 h. Following treatment, cells were
lysed by immunoprecipitation lysis buffer and total cellular proteins (65 !Ag of protein)
were resolved on a 10 % SDS-PAGE and subjected to standard immunoblotting
procedures. The primary antibodies used in this study were as follows: anti-phosphoAkt 1:500; anti-Akt 1:500; anti-Fas-L (C-178) 1:750; anti-FLIPy/8 1:750 and

~-Actin

1: 1000. The appropriate secondary antibodies were used at 1:2000 for phospho-Akt,
total Akt, and FasL; 1:5,000 for FLIPy/8 and

~-Actin.

Proteins signals were visualized

using the ECL system (Amersham Pharmacia Biotech, Piscataway, Nl), as directed by
the manufacturer. The molecular sizes of the developed proteins were estimated by
comparison with prestained protein markers (Invitrogen, Carlsbad, CA).

RNA isolation and real time peR analysis
Method details were described in Chapter II.

Trypan blue dye exclusion
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Method details were described in Chapter II.

Statistical analysis
Analyses were performed as described in Chapter II.

RESULTS
PTCA protects against HNE-induced cytotoxicity
Our previous studies have shown HNE-induced dose-dependent cytotoxicity
and apoptotic cell death in lurkat cells. In this study, lurkat T cells pretreated with
PTCA, a GSH precursor, cell viabilities were increased by about 80% from the
untreated value as compared to 20-25% survival with HNE alone (Fig. 17A).
Pretreatment of lurkat T cells with PTCA, DNA fragmentation, an index of apoptosis,
were decreased to about 1.8-fold of the untreated value as compared to 2.5-fold of cells
treated with HNE alone (Fig. 17B).

PTCA attenuates HNE-induced decreases in GSH concentration
Previously, we found that HNE produced a time-and dose-dependent depletion
of intracellular GSH. The basal GSH concentration was 37.1 ± 8.6 nmol/mg protein.
GSH concentration was 70% depleted by 15 min after HNE treatment and reached a
maximal depletion of 90% at 1 h, and remained low through out 3 h (data not shown).
At the lowest HNE concentration (2.5 ).!M), GSH was 80% depleted at 3 h. At higher
HNE concentrations (5-20 ).!M), GSH was completely depleted. Pretreatment of lurkat
T cells with PTCA markedly attenuated HNE-induced decreases in intracellular GSH
concentration. GSH concentrations in cells pretreated with PTCA were increased to
about 80% of the untreated value as compared to 8% with HNE alone (Fig. 18A).
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Fig. 17. PTCA protects against HNE-induced cytotoxicity. lurkat T cells were
pretreated with PTCA at 250 flM for 1 h before the addition ofHNE at 2.5 or 5 flM.
Cells were untreated (UT), or treated with PTCA (250 flM) or HNE (2.5 or 5 flM), or
PTCA plus HNE. (A) Trypan blue exclusion assay. Cell survival was quantified at 24 h.
Data were normalized to the untreated control (which is set to 100%) and represented as
the mean ± SD of five separate experiments. (B) DNA fragmentation assay.
Cytoplasmic extracts were prepared and analyzed at 6 h for DNA fragmentation by Cell
Death ELISA kit as described in Materials and Methods. Data were normalized to the
untreated control (which is set to 1) and represented as mean ± SD of four separate
experiments. In each experiment, duplicate wells are assayed separately for each
treatment. *P<O.05 compared to UT, a.b P<O.05 compared to HNE 2.5 and 5 !-l M,
respectively.
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From the above results, we plotted the cytotoxicity vs. GSH concentration. As
2

shown in Fig. 18B, there was a close correlation (R =0.9908) between GSH
concentration and cytotoxicity. And it appears that when GSH was depleted to about
80-90% of controls (threshold level), the cytotoxicity was ensued.

Effects of MDA and BSO on intracellular GSH concentrations and cell viability
The effect of MDA (2.5-10 f.lM), another lipid peroxidation product, on
intracellular GSH concentrations was also investigated. As shown in Fig. 19A, the
basal GSH concentrations were 30.6 and 41.9 nmol/mg protein, respectively, at 3 and 6
h. GSH concentrations were 32.7,34.5, and 33.2 nmol/mg protein, respectively, 3 h
after cells exposed to MDA at 2.5, 5 and 10 f.lM. The effects of various doses of MDA
(2.5-10 f.lM) on intracellular GSH concentrations at 6 h were 41. 7, 40.4 and 41.6

nmol/mg protein, respectively. In contrast to the results of HNE, MDA had no effect
on GSH concentration in Jurkat T cells.
BSQ, an inhibitor of GSH biosynthesis, has been demonstrated to decrease
GSH concentrations in many cell lines. As shown in Fig. 19B, Jurkat T cells treated
with BSQ for 24 h, GSH concentrations decreased to 0.511 ± 0.074 nmol/mg protein
(2.5 mM) and 0.02 ± 0.031 nmol/mg protein (5 mM), respectively. Effects of BSQ on
T cell survival was further examined in Jurkat T cells treated with BSQ. Cell
viabilities in the BSQ treated group at 2.5 and 5 mM were 106% and 74% of controls,
respectively (Fig. 19C). The results suggest that BSQ (at 2.5 mM) had no significant
effect on cytotoxicity but depletes intracellular GSH concentrations in Jurkat T cells.
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5

PTCA protects against HNE-induced decrease of Akt activation
The serine/threonine kinase (AktlPKB) has been shown to be critical for T
lymphocyte survival and inhibition of Akt leads to apoptotic T cell death. Our
previous results showed that HNE induced a time-and dose-dependent decreases of pAkt. In untreated Jukat T cells, Akt is constitutively phosphorylated at Ser-473, and
the basal concentration of p-Akt was 28.6 ± 1.0 unit/mg. p-Akt concentrations were
decreased to 73% and 11 % of the untreated values, respectively, on HNE at 2.5 and 5
).lM. In Jurkat T cells pretreated with PTCA, p-Akt concentrations were increased to

about 115% and 70%, respectively, of the untreated value. PTCA alone had no effect
on the p-Akt activation (Fig. 20A).
We further confirmed the increased p-Akt levels by immunoblot analysis on
phospho-Akt and Akt protein expression on cells treated with HNE (2.5 and 5 f!M). As
shown in Fig. 20B, treatment of Jurkat T cells with HNE decreased phospho-Akt
protein expression and PTCA pretreatment protected against HNE-induced
downregulation of phospho-Akt protein at 6 h. We reprobed the same membrane with
anti-Akt primary antibody. The results demonstrated a similar pattern as phospho-Akt
protein expression, indicating that not only phospho-Akt was inactivated but Akt
kinase was depleted 6 h after HNE treatment.
In addition, we plotted GSH concentration vs. p-Akt levels, there was a close
2

correlation (R =0.9668) between the GSH concentration and cell survival as indexed
by p-Akt levels. Thus, the threshold phenomenon in HNE-induced cytotoxicity vs.
GSH (Fig. 18B) shown above was also observed in GSH vs. survival (Fig. 20C). All
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Fig. 20. PTCA protects against HNE -induced downregulation of Akt kinase expression.
Sample preparation was as described in Fig. 18. (A) p-Akt concentration s. Cell extracts
were harvested at 6 h after HNE treatment. Data were normalized to protein
concentration and p-Akt concentration expressed as unitlmg protein. Data are
represented as mean ± SD of three separate experiments. *P<O.OS compared to UT, a.b
P<O.OS compared to HNE 2.S and S [l M, respectively. (B) Western blotting. Total cell
lysates were collected at 6 h for Western blot analysis as described in Materials and
Methods. Akt and phospho-Akt were detected at 6 h by immunoblot ting using an antiAkt and phospho-Akt antibodies. Blots were stripped and reprobed with antibody to ~
actin to ensure equivalent loading. A representative gel out of three experiments is
shown. (C) Relationship between GSH concentration and p-Akt concentrations in Iurkat
T cells. GSH concentration determined at 3 hand p-Akt concentrations at 6 h after HNE
treatment. Each point presented value obtained with a given treatment. Plot includes
data from all experiments in cells in which both GSH and p-Akt concentrations were
determined.
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together, these results suggested that PTCA protects against HNE-induced cytotoxicity
possibly through upregulation of p-Akt.
PTCA decreases HNE-induced PP2A activation
PP2A is serine/threonine phosphatase and studies have shown that PP2A
dephosphorylated and inactivated Akt in vitro (Van Kanegan et aI., 2005). To confirm
the involvement of PP2A in the process of HNE-mediated Akt dephosphorylation, we
examined whether the overall catalytic activity of PP2A was upregulated after HNE
treatement. Using a nonradioactive serine/threonine phosphatase assay kit with the
phosphopeptide K-R-pT-I-R-R as a substrate, we measured the amount of phosphate
released, which indicates PP2A catalytic activity. As shown in Fig. 21A, cells exposed
to HNE (2.5 and 5 [lM) after 30 min, PP2A activities were increased to 150% (202 ±
41 pmol phosphate / /-lg proteinllO min) and 210% (288 ± 28 pmol phosphate / /-lg
proteinllO min), respectively, of the untreated value. Pretreatment of lurkat cells with
PTCA for 1 h before the addition of HNE (2.5 and 5 [lM), PP2A activities were
decreased to 121 % (166 ± 40 pmol phosphate / /-lg protein/ 10 min) and 104% (142 ±
49 pmol phosphate / /-lg protein/ 10 min), respectively, of the untreated value. PTCA
alone had no effect on the PP2A activity. The results on PP2A activity were further
confirmed by protein expression. As shown in Fig. 21B, treatment of lurkat T cells
with HNE (2.5, 5 and 10 [lM) increased PP2A expression on both A subunit (62KDa)
and C subunit (36KDa). Pretreatment of lurkat T cells with PTCA inhibit HNEinduced activation of PP2A protein. Together, the results demonstrated that HNE
induced dose-dependent increases in PP2A activity, which further confirmed by

64

A
*
m
::l

-I:
(1).-

iUE

..1:0

a. ....

111-

o,S

..1:(1)
0. _
_ 0

o 0.. 1
E
a.

UT

PTCA

H 2.5

H 2.5+PTCA

H5

H 5+PTCA

Fig. 21. PTCA inhibits HNE-induced PP2A activation. Sample preparation was as
described in Fig. 17. (A) Cell extracts were harvested at 30 min after HNE treatment.
PP2A activity was measured using PP2A immunoprecipitation assay kit as described in
Materials and Methods. Data were normalized to protein concentration and PP2A
activity expressed as pmol phosphate/I-lg protein/1 0 min. Data are represented as mean ±
SD of three separate experiments. *P<0.05 compared to UT, a P<0.06 compared to HNE 5
/!M. (B) Western blotting. Total celllysates were collected at 6 h for Western blot
analysis as described in Materials and Methods. PP2Ac and PP2Aa were detected at 6 h
by immunoblotting using an anti -PP2Ac and PP2Aa antibodies. Blots were stripped and
reprobed with antibody to ~-actin to ensure equivalent loading. A representative gel out
of three experiments is shown.
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immunoblot analysis. Also, pretreatment of lurkat T cells with PTCA blocked these
effects.

Effects of PTCA on HNE-induced FasL and c-FL1Ps expression
FaslFasL-mediated apoptosis is a common mechanism for T cell death in many
situations including activation-induced cell death (AICD), as well as Akt inhibitioninduced death (Uriarte et al., 2005). In our previous studies, we demonstrated that
HNE-induced apoptosis is through FasL and FADD. Thus, we further examined the
effects of PTCA on FasL expression. As shown in Fig. 22A, treatment of lurkat T
cells with HNE increased FasL expression at higher concentration and PTCA
pretreatment circumvented HNE-dependeRt upregulation of FasL protein at 6 h. To
further investigate if the effect of the above events were at the transcriptional level, we
analyzed FasL mRNA levels by real time-PCR. HNE at 2.5 )..LM had no effect on FasL
mRNA. Similar to FasL expression, pretreatment of lurkat cells with PTCA markedly
reduced the FasL mRNA to about four-fold compared to HNE (5 )..LM) alone (Fig.
22B). Thus, PTCA was shown to down-regulate FasL gene expression induced by
HNE.
c-FLIPs is an anti-apoptotic protein, and has been shown to inhibit Fasmediated apoptosis (Krueger et aI., 2001). Since PTCA protects against apoptosis and
down-regulates FasL expression induced by HNE, we further examined the effects of
PTCA on c-FLIPs expression. Western analysis was performed on lurkat T cells
which showed that c-FLIP s levels were decreased after HNE treatment (Fig. 23).
Treatment of lurkat T cells with PTCA plus HNE (2.5 or 5 )..LM) led to significant
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Fig. 22. PTCA protects against HNE -induced upregulation of FasL. Sample preparation was
as described in Fig. 17. (A) Western blotting. Total celllysates were collected at 6 h for
Western blot analysis as described in Materials and Methods. FasL was detected at 6 h by
immunoblotting using an anti -FasL-specific antibody. Blots were stripped and reprobed with
antibody to ~-actin to ensure equivalent loading. A representative gel out of three
experiments is shown. (B) Real time -PCR. Total RNA was isolat ed from cells, untreated
(UT) or treated witb HNE (2.5 and 5 [!M) at 6 h. FasL mRNA levels were determined by
real time PCR. Data are represented as mean ± S D of five separate experiments. ·P<O.05
compared to UT, a P<O.05 compared to HNE 5 [! M.
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Fig. 23. Effects ofBSO on Akt, p-Akt, FasL and c-FLIPs protein expression. Sample
preparation was as described in Fig. 19B. (A) Western blotting. Total celllysates were
collected at 24 and 48 h for Western blot analysis as described in Materials and Methods.
Akt, p-Akt, FasL and c-FLIPs were detected at 24 h (left panel) or 48 h (right panel) by
immunoblotting using anti-Akt, p-Akt, FasL and c-FLIPy/1> antibodies. (B) Western blotting.
lurkat T cells were pretreated with BSO at 5 mM for 24 h before the addition of MDA at 10
11M at 2 or 24 h. Cells were untreated (UT), or treated with BSO (5 mM) or MDA (lO 11M),
or BSO plus MDA. Blots were stripped and reprobed with antibody to ~-actin to ensure
equivalent loading (data not shown). A representative gel out of two experiments i s shown.
(C) Trypan blue exclusion assay. Sample preparation was described in Fig. 19B. Data were
normalized to the untreated control (which is set to 100%) and represented as the mean ± S D
of five separate experiments. ' P<O.OOl compared to UT, a,bp<O.OI compared to BSO and
MDA, respectively,

increases in c-FLIPs levels. Thus, PTCA was shown to circumvent c-FLIPs
downregulation induced by HNE.

Correlation of GSH content with lipid peroxidation
We have observed that BSO decreases GSH concentrations without affecting
cell viability (Fig. 19). We further examined the effect of BSO on Akt, phospho-Akt,
FasL and c-FLIPs protein expression. As shown in Fig. 24A, treatment of Jurkat T
cells with BSO (2.5 and 5 mM) for 24 and 48 h, phospho-Akt was not changed at 24 h,
but was decreased slightly at 48 h. In correspondence with BSO treatment on survival
(Fig. 19C), there was no change on total Akt protein expression both at 24 and 48 h.
The results suggest that inhibition of GSH-concentration may slightly induce Akt
inactivation through dephosphorylation, but total Akt protein expression was not
affected. Further, we found that BSO has no effect on FasL and c-FLIPs protein
expression.
Since HNE significantly decreased T cell survival and GSH concentration, we
then examined the effect of another lipid peroxidation product, MDA, on T cell
survival. Jurkat T cells treated with MDA (10 IlM) or BSO (5 mM) alone had no effect
on cell viability (Fig. 24C). However, pretreatment of Jurkat cells with BSO before the
addition of MDA (10 IlM) significantly decreased Akt and phospho-Akt expression
(Fig. 24B) as well as produced a profound cell death (33% of controls) (Fig. 24C).
These results demonstrated that GSH depletion caused by BSO sensitizes Jurkat T cells
to the secondary hit caused by lipid peroxides and induces the potentiation of
cytotoxicity, suggesting that GSH may play an important role in T cell viability.
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Fig. 24. Effects of BSO on Akt, p-Akt, FasL and c-FLIPs protein expression. Sample
preparation was as described in Fig. 20B. (A) Western blotting. Total celllysates
were collected at 24 and 48 h for Western blot analysis as described in Materials and
Methods. Akt, p-Akt, FasL and c-FLIPs were detected at 24 h (left panel) or 48 h
(right panel) by immunoblotting using anti-Akt, p-Akt, FasL and c-FLIPy/o antibodies.
(B) Western blotting. Jurkat T cells were pretreated with BSO at 5 mM for 24 h before
the addition of MDA at 10 JlM at 2 or 24 h. Cells were untreated (UT), or treated with
BSO (5 mM) or MDA (10 JlM), or BSO plus MDA. Blots were stripped and reprobed
with antibody to ~-actin to ensure equivalent loading (data not shown). A
representative gel out of two experiments is shown. (C) Trypan blue exclusion assay.
Sample preparation was as described in Fig. 8B. Data were normalized to the untreated
control (which is set to 100%) and represented as the mean ± SD of five separate
experiments. *P<O.OOI compared to UT, a,b p <O.OI compared to BSO and MDA,
respectively.
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DISCUSSION
Clinical studies have demonstrated that oxidative stress is an important
pathological factor in several immunosuppressive diseases. A critical factor in
immunosuppression is the loss of CD4+ T lymphocytes, which are the central
regulators of both cell-mediated and humoral immune responses (Cook, 1999). In
chapter II, we demonstrated that HNE induces Fas-mediated apoptosis and cytotoxicity
in lurkat T cells. However, the underlying mechanism is not clear. Numerous studies
suggest that intracellular events such as GSH depletion, caspase activation, DNA
fragmentation, chromatin condensation, and cytochrome c release may be involved in
the apoptotic pathway initiated by HNE (Uchida, 2003). The present study focuses on
the role of GSH in HNE-induced toxicity as well as the possible cytoprotection by a
GSH precursor, namely PTCA.
Role of GSH in Cytotoxicity
GSH is the most abundant antioxidant in the body. It plays an important role in
the circumvention of cellular oxidative stress and in the maintenance of intracellular
thiol redox status (Khanna et aI., 1998). Clinically, a decreased level of cellular GSH
has been observed in association with a number of pathological conditions including
diabetes, liver cirrhosis, drug poisoning, age-related disorders, and AIDS (Sen, 1997).
In addition, GSH content in many cultured cell lines including lurkat T lymphocytes
plays an important role in cell cycle, function, proliferation, and survival (Soderdahl et
aI.,2003). Previously, we found that HNE decreases intracellular GSH in a dose- and
time-dependent manner, and their correlates with the induction of DNA fragmentation.
The HNE-induced decreases in intracellular GSH concentration could be due to the
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utilization of GSH by HNE to form HNE-GSH adducts. In the present study,
restoration of intracellular GSH levels achieved by PTCA, a GSH precursor, on cell
survival and GSH enhancement was observed. PTCA functions similar to NAC by
supplying Cys for GSH synthesis in a prodrug form, but PTCA releases Cys
spontaneously and is independent of enzymatic hydrolysis (Nagasawa et aI., 1984).
Our work is the first demonstration that PTCA attenuates HNE-induced cytotoxicity is
possibly due to GSH restoration in Jurkat T lymphocytes. PTCA has been shown to
attenuate AP AP- and PAP-induced hepatic GSH depletion and hepatotoxicity in mice
(Srinivasan et aI., 2001) and hamsters (Fu et aI., 2004). Studies have shown that PTCA
restored the AP AP-induced depletion of total hepatic and mitochondria GSH in SwissWebster mice (Nagasawa et aI., 1984). Other antioxidant such as NAC was shown to
block HNE-induced DNA fragmentation in Jurkat cells (Liu et aI., 2000). Others have
also shown that pretreatment of Jurkat cells with anethole dithiolethione (10-50 mM,
18 h) attenuated HNE and H20 2-induced cytotoxicity and GSH depletion (Khanna et
aI., 1998). In HIV -infected patients, NAC administration resulted in a relative increase
in the CD4/CD8 ratio (Look et aI., 1998) and a slower decline of the CD4+ T cell count
(Akerlund et aI., 1996). However, there is controversy over changing GSH
concentrations. L-2-0xothiazolidine 4-carboxylate, another Cys precursor,
significantly increased serum GSH concentrations in HIV -infected patients (Raju et aI.,
1994). Together, our results along with others suggest that GSH plays an important
role in HNE-induced cytotoxicity. Further, PTCA protects against HNE-induced
cytotoxicity, possibly mediated by increasing intracellular GSH concentrations.
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Unlike the profound effect ofHNE on T cell GSH depletion, our results showed
that MDA (2.5-10 !lM), another lipid peroxidation product, had no effect on GSH
levels either at 3 or 6 h, suggesting that GSH is attacked by HNE to a greater effect
from MDA. BSO, an inhibitor of GSH biosynthesis, has been shown to disturb the
redox balance and enhance the vulnerability ofPC12 cells to oxidative stress (Seyfried
et aI, 1999). In contrast to the effect of PTCA on GSH enhancement, pretreatment with
BSO for 24 h, significantly depleted GSH without affecting T cell viability (Fig. 19).
Similar studies were performed with diethyl maleate (DEM), a GSH scavenger. It
depletes GSH within 1 h in hepatocytes and produces no appreciable change in cell
viability (Chen et al., 2005). Additional studies have focused on the sensitization of
cells to oxidative stress. Spitz et al. (1991), demonstrated that pretreatment of Chinese
hamster fibrcblasts and clonogenic cells with BSO potentiates HNE-induced
cytotoxicity by causing about 90% depletion of GSH, which corresponds with a loss in
the cell ability to metabolize HNE. Others also have demonstrated a significant
increase of cytotoxicity in hepatocytes with a combination ofBSO and S-nitroso-Nacetyl-D,L-penicillamine, a nitric oxide donor. This combined regimen led to an
increase in LDH release and oxidative stress, disruption of mitochondrial membrane
potential, and a decrease in ATP content (Chen et al., 2005). These results agree with
our finding

~hat

GSH depletion sensitized T cells to the effect ofMDA (Fig. 24C).

A pl<Dt of cell viability vs. GSH concentration under the different experimental
conditions olfthis study (Fig. 18B) demonstrates a GSH threshold phenomenon in
HNE-induced cytotoxicity in CD4+ T lymphocytes, which was also observed in in vivo
studies (Fu ¢t al., 2004). There was no decrease in T cell viability at GSH
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concentratioQ.s approximately above 20% of the untreated controls. Thus, intracellular
GSH plays aJIl important role in cell viability; at GSH depletion of 80-90%, which most
likely involv¢s depletion of mitochondria GSH, results in cytotoxicity.
Role of GSa in the survival factor, Akt

The serine-threonine kinase Akt (or PKB) is critical for survival and protection
against apop~osis in various cells (Burgering and Coffer, 1995; Franke et aI., 1995).
Specifically ~n T lymphocytes, the balance between survival and apoptosis is directly
associated with immune function. Up-regulated Akt promotes cell survival by
phosphorylat~ng

a variety of downstream key proapoptotic targets such as GSK-3

(Cross et aI., 1995) and caspase-9 (Cardone et aI., 1998), and activating transcriptional
factors such as NFxB and Forkhead (Kops and Burgering, 1999) in T lymphocytes.
Results in th¢ first chapter have shown that HNE downregulated Akt phosphorylation
and activation. In the present study, we found that PTCA pretreatment attenuates
HNE-induced decreases of Akt activation (Fig. 20). Similarly, NAC, a Cys precursor,
has been shown to activate Akt and decrease apoptosis in Jurkat T cells by blocking
adaphostin-mediated ROS generation (Yu et aI., 2004). Others have shown that NAC
completely reversed N-ethylmaleimide-induced inhibition of Akt phosphorylation and
apoptosis via inactivation of PP2A in vascular smooth muscle cells (Yellaturu et aI.,
2002). Interestingly, Liu et aI. (2003) showed that pretreatment of the Jurkat T cells
with Cys before HNE restored the activity of Akt almost to the untreated levels. They
further demonstrated that inhibition ofPP2A by a PP2A inhibitor, okadaic acid,
prevented HNE-induced Akt dephosphorylation. It is likely NAC, as well as PTCA,
reversed ROS induced dephosphorylation of Akt. Thus, PTCA protects against HNE-
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induced inactivation ofPI3K1Akt, possibly mediated by restoring phosphorylation of
Akt kinase through downregulation and association of PP2A.
GSH is critical for ETV6-NTRK3-transformed murine fibroblast cell growth
and studies demonstrated that depletion of GSH by BSO inhibited p-Akt
phosphorylation in these transformed cells (Kim et aI., 2005). In addition, another
GSH depleting agent, DEM, was shown to inhibit p-Akt expression in rat fibroblast
cells (Esposito et aI., 2003). In contrast, we have not observed any changes in active or
total Akt levels in cells treated with BSO for less than 24 h, when 90% of GSH was
depleted (Figs. 19 and 24). Most of the above experiments were performed by
exposing cells to different concentrations and conditions of ROS. In our model, we
treated Jurkat T cells with BSO in a complete (10%) serum RPMI medium; however,
others starved the fibroblasts for 48 h before DEM addition (1 mM, 30 min). Also, it
could yield different effects on Akt downregulation via different targets within specific
cell types such as ETV6-NTRK3 cell, which are especially sensitive to GSH for basal
cellular functions (Kim et aI., 2005). Interestingly, our results showed that the extent
of GSH depletion (48 h BSO treatment) and/or second oxidant addition (10 11M MDA)
inhibited Akt activation either through dephosphorylation or a significant degradation
of Akt kinase. Together, we and others demonstrated that loss of Akt phosphorylation
as well as loss of viability was potentiated if the cell sensitized by GSH depletion
before or after oxidative stress.
A plot of p-Akt level vs. GSH concentration under different experimental
conditions (Fig. 20C) shows a similar GSH threshold phenomenon as that of HNEinduced loss of survival in CD4+ T cells (Fig. 18B). Cells are viable as indexed by p-
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Akt concentration as long as intracellular GSH concentration is maintained at about
20% of basal levels. This study demonstrated for the first time the close relationship
between GSH, cytotoxicity, and cell survival. Also the results suggest that the active
Akt is tightly regulated by intracellular GSH concentration.
Previously, we reported that PP2A is upregulated promptly under HNE
treatment and PP2A and Akt simultaneously regulate HNE-induced cytotoxicty,
however, the mechanism is still not clear. PP2A is a trimeric enzyme composed of a
catalytic subunit (PP2Ac), a constant regulatory subunit (PR-65 or PP2Aa) and a
variable regulatory subunit (B, B'B"). It has been suggested that PP2A, as other
Ser/Thr phosphatases, plays a role in apoptosis (Gjertsen and Doskeland, 1995),
probably via phosphorylation and dephosphorylation oftarget proteins in the survival
and/or apoptotic signaling pathways. Our present studies demonstrate for the first
time, that PTCA pretreatment attenuated HNE-induced increases of PP2A activation in
lurkat T cells. Analysis of celllysates by antibodies directed at the PP2A regulatory A
subunit demonstrated the loss of this subunit at 6 h. At the same time, there was less of
a decrease in the amount of the catalytic subunit (Fig. 21). Similarly, others
demonstrated that lurkat cells treated with anti-Fas antibody increased PP2A activity
and protein expression, then caspase-3 inhibitors pretreatment would significantly
protect against this enhancement (Santoro et aI, 98). Our results and those of others
suggest the possibility that upregulating PP2A activity is due to cleavage and removal
of the regulatory A subunit from the core enzyme. Also it suggests that without the
regulatory A subunit, the catalytic C subunit is still stable in the cytosol. However, our
results further demonstrate the novelty that PTCA, an antioxidant, inhibits HNE-
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induced PP2A upregulation and Akt downregulation followed by apoptotic cell death is
regulated by increasing phosphoryaltion of Akt kinase.
Role of Akt in Fas-mediated signaling
Akt is involved in the inhibition of Fas-mediated apoptosis by associating with
intracellular GSH levels, lymphokine and co-stimulatory molecules (Hausler et ai.,
1998). Others have demonstrated that Akt kinase regulates FasL expression and DNA
fragmentation in vascular smooth muscle cells and cervical cancer (HeLa) cells
(Suhara et ai., 2002; Uriarte et ai., 2005). Previously, our laboratory showed that Akt
inhibition by L Y294002 induces FasL expression and subsequent Fas-mediated
apoptosis in Jurkat T cells (Uriarte et ai., 2005). The present studies showed that
exposure of T cells to HNE results in inhibiting of Akt activation that leads to FasFasL-dependent apoptosis in Jurkat T cells. However, we observed no increases in
FasL transcripts at the lower HNE concentration (2.5IlM), which may be due to: 1)
downregulation of Fas expression in cells or 2) regulation by a posttranscriptional
mechanism. There are variety of effectors and repressors that lie upstream and
downstream in the Fas-mediated cell death machinery, along with the recruitmentactivation pathway. This regulation may occur at the level of receptors, such as
receptor endocytosis or hydrolysis of membrane-bound FasL by metalloproteinase to a
soluble form. Most importantly, regulation of c-FLIPs plays a role in blocking the
association of caspase-8 with FADD in the early stage of signal transduction. c-FLIP s
is a cytoplasmic protein and has sequence homology with caspase-8, and blocks
apoptosis by competitively inhibiting caspase-8 in human keratinocytes (Marconi et ai.,
2004). Our results demonstrate that HNE induced Fas-mediated apoptosis also leads to
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c-FLIP s downregulation. However, the mechanism ofthe antiapoptotic regulation of
c-FLIP s in T cells treated with HNE is not completely understood. Studies have shown
that Akt regulates Fas-mediated death signals through c-FLIP s expression in
endothelial cells (Suhara et aI., 2001). Adenovirus-mediated transfection of
constitutively active Akt gene abolished homocysteine-mediated downregulation of cFLIP in endothelial cells (Suhara et aI., 2004). Others demonstrated that the PI3-kinase
inhibitor, wortmannin, partially suppressed eicosapentaenoic acid (EP A)-induced cFLIPs restoration in endothelial cells (Suzuki et aI., 2003). Together, our result suggest
that Akt directly upregulated c-FLIP s expression and prevented Fas-mediated
apoptosis.
Effect of PTCA on Fas-mediated signaling

In the present study, we have shown that PTCA restored intracellular GSH
concentrations, which could then prevent HNE-induced FasL expression both at the
protein and transcriptional levels (Fig. 22). Others have also found that inhibition of
tert-butylhydroperoxide (tBH)-induced FasL expression, along with antioxidants GSH

and NAC, blocked tBH-induced apoptosis in human retinal pigment epithelial cells
(Jiang et aI., 2000). It is well known that expression of FasL is under redox regulation
(Kasibhatla et aI., 1999). Upon Fas triggering (a-APO-l) with the antibodies (CH-ll),
BSO depleted GSH by inhibiting its biosynthesis, increases Fas DISC formation in
leukemia cells (Friesen et aI., 2004). We further demonstrated that PTCA prevents
HNE-induced c-FLIPs downregulation, as well as Akt inactivation. To our knowledge,
this is the first report that GSH plays a role in HNE-induced Fas-mediated apoptosis by
preventing the loss ofp-Akt and c-FLIPs expression in human T lymphocytes. Others
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have shown that pretreatment of multiple myeloma cells with NAC or DTT blocked
oleanane triterpenoid-induced apoptosis and c-FLIP s downregulation (Ikeda et aI.,
2004). Our results clearly indicate that restoration of GSH by PTCA protects against
HNE-induced Fas-mediated apoptotic cell death, which is mediated through redox
sensitive Akt and c-FLIPs signaling molecules.
Overall, our study demonstrates that, in addition to other known antiapoptotic
functions, GSH regulates Akt kinase in T lymphocytes; this involves the regulation of
Fas-mediated upstream apoptotic cell death, as well as FasL and c-FLIP s expression.
PTCA protects against HNE-induced toxicity and could possibly be used in the
treatment of oxidative stress-induced immunosuppressive diseases.
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CHPATERIV
ROLE OF MAT AND SAME IN HNE-INDUCED CYTOTOXICITY

INTRODUCTION

The studies of HNE toxicity in human CD4+ T lymphocytes described in this
chapter were designed to test the possible role of SAMe and MAT II in toxicity. In an
attempt to assess MAT expression, extractions from HNE treated cells were analyzed
for MAT II enzymatic activity and gene transcription. To evaluate the role of SAMe
and GSH in toxicity, the effects of HNE on SAMe concentrations and the ability of
PTCA protects against HNE-induced MAT downregulation and SAMe depletion were
determined. To evaluate the role of transcriptional activator of MAT 2A in toxicity,
the effects of HNE on c-Myb expression and PTCA protection on HNE toxicity were
examined.

MATERIALS AND METHODS
Cell culture

lurkat T cells were obtained and prepared as described in Chapter II.
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Chemicals
SAMe, heptane sulfonic acid, MPA, and SAH were purchased from Sigma
Chemical Co. (St. Louis, MO). Anti-caspase-3 and p-Actin antibodies were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA).
RNA isolation and real time PCR analysis
Reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to
assess MAT 2A mRNA levels in Jurkat T cells. The specific primers were designed
for human GAPDH and MAT 2A using Primer3 software program. The following
primers were used in real time PCR:
hGAPDH-RT-FPl:

5' TGGGCTACACTGAGCACCAG 3'

hGAPDH-RT-RPl:

5' GGGTGTCGCTGTTGAAGTCA 3'

hMAT2A FP

5' ACAATCTACCACCTACAGCCAAGT 3'

hMAT2A RP

5' GCATAAGAGACCTGAACAAGAACC 3'

The relative gene expression of MAT2A was analyzed using 2-MCt method as
described in Chapter II.
MA T activity assay
15 x 106 Jurkat cells were homogenized in 500 !!l cold 10 mM Tris-HCI, pH
7.5, containing 0.3 M sucrose, 0.1 % p-mercaptoethanol, 1 mM benzamidine, 0.1 mM
PMSF and 10 !!glml soybean trypsin inhibitor. Cells were subjected to 3 cycles of
freezing/thawing and then were centrifuged (100,000 x g for 30 min) for the extraction.
An aliquot of 160 !!l from the resulting supernatant was incubated with 90 !!l of
reaction mixture containing 75 mM Tris-HCI, pH 8, 250 mM KCI, 9 mM MgCh, 10
mM DTT, 5 mM ATP and 5 mM methionine. The incubation was performed for 30
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min at 37°C and was stopped by the addition of 70 !-ll 25% MPA (on ice). Samples
were centrifuged at 10,000 x g for 2 min. The supernatants were collected for HPLC
analysis. MAT activity was obtained from the net SAMe formation (subtracted
intracellular SAMe) and expressed as nmol of SAMe formed per 30 min.
Analysis of SAMe
The intracellular concentrations of SAMe were assayed by reverse-phase HPLC
in deproteinized extracts of cells by a modified method of Merali et aI. (2000). Cell
pellets were mixed with 0.25 ml of 4% MPA and centrifuged at 10,000 x g for 2 min.
The supernatants were collected for HPLC analysis. The HPLC system included a
Waters 501 pump, a manual injector, and a 5 !-lm Hypersil C18 reverse-phase column
(250 x 4.6 mm). The mobile phase consisted of 40mM ammonium phosphate, 8mM
heptane sulfonic acid (ion-pairing reagent) and 6% acetonitrile (pH 5.0) and was run
isocratically at a rate of 1.0 ml/min. SAMe was detected using a Waters 740 detector
at 254 nm. Standard solutions of SAMe and SAH were prepared in 4% MP A. An
internal standard, SAE, was added to all samples and standard solutions at a
concentration of 100 nmol/ml (Merali et aI., 2000; Chen et aI., 1990).
Western blot analysis
Following treatment, cells were lysed by immunoprecipitation lysis buffer and
total cellular proteins (65 !-lg of protein) were resolved on 10% SDS-PAGE and
subjected to standard immunoblotting procedures. The primary antibodies used in this
study were as follows: anti-caspase-3 1: 100 and p-Actin 1: 1000. The appropriate
secondary antibodies were used at 1:5000 for p-Actin and 1: 15,000 for caspase-3.
Proteins signals were visualized using the ECL system, as directed by the
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manufacturer. The molecular sizes of the developed proteins were estimated by
comparison with prestained protein markers.

Statistical analysis
Analyses were performed as described in Chapter II.

RESULTS
Our previous studies have shown that HNE decreased intracellular SAMe
concentrations in lurkat T cells. The basal intracellular SAMe concentration was 1.1 ±
0.14 nmol/mg, and HNE significantly decreased SAMe levels at 6 h. The extent of
SAMe depletion by HNE (2.5-20

~M)

was about 50% of the control level.

Interestingly, even at the low HNE (2.5

~M)

concentration, the SAMe levels was

reduced to 50% of controls.

HNE decreases MAT II activity
MAT II is a critical enzyme in cellular metabolism and catalyzes the formation
of SAMe from L-methionine and ATP. To determine whether HNE induced depletion
of SAMe is due to an effect on MAT II activity, we measured this enzyme activity. As
shown in Fig. 25, the MAT II activity of untreated cells was 6.5 ± 0.4 nmol/ml/30min.
With increasing concentrations ofHNE (2.5, 5, and 10 ~M) MAT II activities were 92,
55 and 21 %, respectively, of the untreated value. The lowest MAT II activity (1.4 ±
0.4 nmol/ml/30min) was observed in cells exposed to 10

~M

HNE. These results

demonstrated that HNE induced a dose-dependent decrease in MAT II activity in
lurkat T cells.
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Fig. 2S. HNE decreases MAT II activity. lurkat T cells were untreated (UT) or treated
with various concentrations ofHNE (2.S, S, and 10 11M) for 6 h. MAT II activities were
assayed at 6 h by the formation of SAMe using HPLC metho d as described in Materi als
and Methods. Data are represented as mean ± S D of three separate experiments. *P<O.OS
compared to UT.
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HNE downregulates MAT 2A gene expression
Upon T cell activation, a key mechanism for the increase in SAMe biosynthesis
is increased transcription of MAT 2A, which is a catalytic subunit of MAT gene. We
further examined the effect of HNE on MAT 2A gene expression. Total RNA was
isolated from cells exposed to HNE (2.5, 5 and 10 )..lM) for 3 h and MAT 2A mRNA
levels were assessed by real time PCR. As shown in Fig. 26, MAT 2A mRNA was
significantly decreased to 0.6-, 0.4- and O.2-fold, respectively, of untreated value.
HNE was found to decrease MAT 2A mRNA expression in a dose-dependent manner.

Effects of PTCA on SAMe and MAT
PTCA, a GSH precursor, has been shown to protect against cytotoxicity in
CD4+ T lymphocytes. Our previous studies have shown that PTCA markedly
attenuated HNE-induced decreases in intracellular SAMe concentrations to about 50%
of the untreated control. PTCA alone had no effect on SAMe concentrations. In lurkat
T cells pretreated with PTCA, SAMe concentrations were increased to about 90% of
the untreated control.
Whether PTCA attenuation of HNE-induced SAMe depletion is related to an
effect on MAT activity is not known. We examined the effects of PTCA on MAT II
activity. As shown in Fig. 27, MAT II activity of untreated cells was 6.5 ± 0.4
nmollml/30min. Treatment of lurkat T cells with increasing concentrations of HNE
(2.5,5, and 10 )..lM) resulted in MAT II activities that were 93, 55 and 21 %,
respectively, of the untreated values. In lurkat T cells pretreated with PTCA before the
addition ofHNE (2.5, 5 and 10 )..lM), MAT II activities were increased to 102,82 and
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Fig. 26. HNE decreases MAT 2A mRNA levels. Jurkat T cells were prepared as
described in Fig. 25. Total RNA was isolated at 3 h from cells untreated (UT) or treated
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Fig. 27. PTCA attenuates HNE-induced decreases of MAT II activity. lurkat T
cells were pretreated with PTCA at 250 11M for 1 h before the addition of HNE at
2.5, 5 or 10 11M. Cells were untreated (UT), or treated with PTCA (250 11M) or
HNE (2.5, 5, and 10 11M), or PTCA plus HNE. MAT II activities were assayed at
6 h by the formation of SAMe using HPLC method as described in Materials and
Methods. Data are represented as mean ± S D of three separate experiments.
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Fig. 28. PTCA attenuates HNE-induced decreases MAT 2A mRNA. Jurkat T
cells were prepared as described in Fig. 27. Total RNA were isolated from Jurkat
T cells at 3 h, and MAT 2A mRNA levels were determined by real time PCR.
Data are normalized to the untreated control (which is set to 1) and represented as
mean ± SD of four separate experiments. 'p< 0.05 compared to UT, .,b,c P< 0.05
compared to HNE 2.5, 5 and 10 I-lM, respectively.
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33 %, respectively, of the untreated value. These results demonstrated that PTCA
attenuates HNE-induced decreases in MAT II activity.
Furthermore, a close correlation exists between the GSH concentrations vs.
MAT II activity (R2=0.9731). As shown in Fig. 29, it appears that there is a threshold
concentration of GSH of 90-95% depletion before the MAT II activity decreases
occurred.
The effect of PTCA on HNE reduced MAT 2A gene expression was further
investigated. Total RNA was isolated from the cells pretreated with PTCA for 1 h
before addition of HNE, and MAT 2A rnRNA levels were assessed by real time PCR
after 3 h. As shown in Fig. 28, MAT 2A mRNA levels were significantly decreased to
0.6-,0.4- and 0.3-fold, respectively, of untreated value at HNE concentration of 2.5, 5
and 10 /-lM. In Jurkat T cells pretreated with PTCA before addition of HNE (2.5, 5 and
10 /-lM), MAT 2A mRNA levels were increased to about 1.8-fold of the untreated
value. PTCA alone had no effect on MAT 2A mRNA expression. Thus, PTCA
markedly upregulates HNE-induced decreases on MAT 2A gene expression.

PTCA vs. c-Myb expression
Since c-Myb is the transcriptional factor which up-regulates MAT 2A
expression in activated Jurkat T cells, the effect of HNE on c-Myb expression was
examined by immunoblot analysis. Similar to the effect of HNE on MAT 2A mRNA
expression (Fig. 26), HNE was found to downregulate c-Myb in a dose-dependent
manner (Fig. 30). At the highest concentration (10 /-lM) ofHNE, c-Myb was blocked
completely. Further, PTCA pretreatment protects against HNE-induced c-Myb
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Fig. 29. Relationship between intracellular GSH concentrations and MAT II
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Fig. 30. PICA protects against HNE-induced c-Myb expression. Jurkat T cells were
prepared as described in Fig. 27. Total celllysates were collected at 6 h for Western blot
analysis as described in Materials and Methods. c-Myb was detected at 6 h by
immunoblotting using an anti -c-Myb antibody. Blots were stripped and reprobed with
antibody to (3- actin to ensure equivalent loading. A representative gel out of three
experiments is shown.

downregulation. PTCA alone slightly increased expression of c-Myb. The results
suggested that c-Myb is downregulated by HNE and PTCA protected against c-Myb
downregulation, thus it is probably mediated by a redox sensitive transcription factor.

PTCA vs. Caspase-3 activation
Our previous studies have shown that PTCA, a GSH precursor, protects against
HNE-induced cytotoxicity and apoptotic cell death. In lurkat T cells pretreated with
PTCA, DNA fragmentation, an index of apoptosis, was decreased to about 1.8-fold of
the untreated value as compared to 2.5-fold decrease in cells treated with HNE alone
(previous study).
Caspase-3 is the main executioner caspase, and its activation plays a critical
role in downstream apoptosis signaling and leads to DNA fragmentation. We
examined caspase-3 activation in lurkat T cells treated with HNE (2.5, 5 and 10 [!M)
alone 1 h following pretreated with PTCA. As shown in Fig. 31, HNE-induced a
significant activation of caspase-3 by increasing the cleavages from procaspase-3 (at
32KDa) to active caspase (at p17-20KDa) in a dose-dependent manner. PTCA
pretreatment protected against the cleavage of procaspase-3. Additionally, PTCA
produced no increase in cleavage products, suggesting that PTCA had no effect on
caspase-3 activation. The results showed that HNE-induces caspase-3 dependent
apoptosis and PTCA pretreatment protects against caspase-3 activation induced by
HNE.
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Fig. 31. PTCA protects against HNE-induced caspase-3 dependent apoptosis. lurkat T
cells were prepared as described in Fig. 27. Total celllysates were collected at 8 h for
Western blot analysis as described in Materials and Methods. Untreated cells (UT) were
used as a negative control. Pro (32KDa) and active (20KDa) caspase-3 was detected at 8 h
by immunoblot ting analysis. Blots were stripped and reprobed with antibody to ~-actin to
ensure equivalent loading. A representative gel out of three experi ments is shown.

DISCUSSION
Methionine adenosyltransferase (MAT, EC 2.5.1.6) is the rate limiting enzyme
that catalyzes the biosynthesis of SAMe from L-methionine and ATP (Cantoni, 1953).
Various studies have shown the relevance and importance of SAMe and MAT in
oxidative stress-induced hepatic damage (Lu, 2000). Administration of BSO, an
inhibitor of GSH biosynthesis, leads to a 60% decrease of hepatic MAT activity in
Wistar rats (Corrales et aI., 1991). APAP administration induced a 72% suppression of
MAT activity concomitant with GSH depletion in Swiss-Webster mice (Shirota et aI.,
2002). Clinically, patients with alcoholic cirrhosis have decreased SAMe biosynthesis
due to decreased expression of MAT 1A and hepatic MAT activity (Mato et aI., 2002).
Previously, our laboratory has shown that ethanol treatment produced a significant
reduction of MAT 2A and MAT II in MOLT -4 and lurkat T cells. These notions led
us to study whether MAT II could be targeted by oxidative agents, such as the lipid
peroxidation end products, and HNE in different tissues, such as lymphocytes. Along
with similar results in liver from other studies, we were the first to observe that HNE
treatment effectively inhibited MAT II activity in a dose dependent manner in lurkat T
cells.
The MAT 2A gene encodes the MAT II isozyme and is expressed wildely in all
tissues including fetal and transformed hepatocytes and cells such as erythrocytes and
lymphocytes (Kotb and Kredich, 1985). MAT 2A gene expression is deeply
influenced by the cell cycle and is correlated with cell proliferation (De La Rosa et aI.,
1995). Consistent with this finding, studies have shown that IL-2 and phorbol ester
stimulated MAT 2A expression in lurkat T cells (LeGros et aI., 1997). Dexamethasone
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(DEX), a known inhibitor of T-Iymphocyte activation, blocked IL-2 and phorbol12myristate 13-acetate (PMA)-mediated regulation of MAT 2A expression. Interestingly,
DEX treatment alone had no effect on the basal mRNA level of MAT 2A (Zeng et aI.,
2001). Our results showed that not only does HNE significantly inhibit MAT II
activity, but this decrease correlated with the decay in MAT 2A mRNA levels. Thus,
these results suggest that the MAT 2A gene is targeted by HNE.
SAMe, as a methyl donor, is involved in the production of nucleic acids (DNA
and RNA), proteins, neurotransmitters, hormones, and phospholipids, and it functions
as an antioxidant. SAMe is also required for cell proliferation. In fact, upon activation
of T -lymphocytes, both the SAMe pool size and the rate of SAMe utilization increase
and is accompanied by induction of MAT 2A and MAT II (Honchel et aI, 1992; De La
Rosa et aI., 1992). Most importantly, the inhibition of SAMe biosynthesis blocks T
cell proliferation (German et aI., 1983; Kotb and Geller, 1993). SAMe also functions
as a GSH precursor through the transsulfuration pathway. Studies have shown that
decreases in SAMe result in GSH deficiency under oxidative stress (Honchel et aI,
1992; Wang and Spitzer, 1997). An increased flux of 13C-Iabeled methionine into Sadenosylhomocysteine (SAH) in human lung epithelial-like (A549) cells demonstrated
the utilization of SAMe. In addition, the formation of cystathionine increased,
indicating that at least part of the SAMe generated was directed toward cysteine/GSH
in the transsulfuration pathway (Panayiotidis et aI., 2006). Our previous work
demonstrated that HNE significantly decreased intracellular SAMe and GSH
concentrations. Compared with the time course of GSH depletion (previous studies)
and to Fas-mediated apoptotic signaling, HNE decreased intracellular SAMe at a later
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time point (6 h, previous study). These results suggest that SAMe depletion occurs: 1)
at least in part, when there is an inhibition of methionine breakdown at the level of the
SAMe synthesis; 2) after the extensive utilization of GSH through the transsulfuration
pathway by HNE. The concomitant decrease in hepatic SAMe and GSH
concentrations was also observed in alcoholic patients and chronic alcoholic diet feed
animal models (Sprague-Dawley rats) (Koch et aI., 1991; Honchel et aI, 1992; Wang
and Spitzer, 1997).
Rest(J>ration of intracellular SAMe levels has been shown to playa role in
maintaining MAT 1A gene expression and protecting against cytotoxicity in rat
hepatocytes, suggesting it is a "proof of concept" supplementation (Lu and Mato,
2005). However, there are several disadvantages using SAMe supplementation
directly whiah include: 1) difficulty in crossing membranes; 2) low biological
availability by oral or parenteral administration; 3) two biological isomers (the inactive
R,S and the active S,S forms) in the medium; 4) high cost. Our preliminary study has
shown that SAMe pretreatment potentiated HNE induced cytotoxicity in Jurkat T cells,
though the aSH and SAMe concentrations were increased. Others observed a rapid
elevation of serum aminotransferases such as ALT and AST during SAMe treatment of
patients with liver diseases. Thus, SAMe administration is considered to be
controversial.
In thils study, we observed the effect of PTCA, a GSH precursor, on
intracellular SAMe concentration. PTCA has been shown to block APAP-induced
GSH depletion and hepatotoxicity in rats and mice (Song, 1994; Fu, 2001). PTCA
functions similar to NAC by supplying Cys for GSH synthesis in a prodrug form; but
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PTCA releases Cys independently from enzymatic hydrolysis. We have shown that
PTCA attenuated GSH depletion, thereby preventing HNE toxicity in lurkat T cells.
Shirota et aI. (2002) have shown that NAC attenuates APAP-induced hepatic depletion
of GSH and SAMe in Swiss-Webster mice by maintaining MAT activity. Others have
also shown that GSH concentration regulates MAT activity in rat liver during
ischemia-reperfusion (Ito et aI., 1999). Together, PTCA significantly restores SAMe
concentration in lurkat T cells possibly through the transsulfuration pathway.
A plot of MAT II activity vs. GSH concentration under different experimental
conditions (Fig. 29) shows a similar GSH threshold phenomenon as that of HNEinduced loss of survival and p-Akt level in CD4+ T lymphocytes (Figs. 18 and 20).
These and earlier results support the concept that a reduction in GSH to 20% of control
levels may be critical for cell survival. HNE-mediated decreases in intracellular GSH
concentrations could then result in an inactivation of MAT II as well as decrease
SAMe levels.
Our results further demonstrated a 2 to 3-fold increase on MAT 2A mRNA in
lurkat T cells pretreated with PTCA, compared to HNE alone. Others have shown that
NAC and PTCA attenuate APAP-induced decreases of MAT activity in Swiss-Webster
mice (Shirota et aI., 2002). Administration of the antioxidant coenzyme Q 10 to rats
prior to ischemia protected against both the reductions in MAT activity and the hepatic
GSH level induced by ischemia-reperfusion (Ito et aI., 1999). In A549 and lurkat cells,
MAT 2A mRNA levels were significantly increased during hyperoxia (95% O2) (Ito et
aI., 1999; Zeng et aI., 2001). Together, these results directly support the important role
GSH plays in the activation of the MAT 2A and the MAT II enzyme which is redox
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sensitive reaction. Further, we observed the involvement of the transsulfuration
pathway in the metabolic response to HNE in lurkat T cells.
The effect of HNE on the MAT 2A gene expression is likely to be a result of its
effect on the MAT 2A transcriptional regulator, c-Myb. c-Myb is a 75- to 80-KDa
protein that functions as a transcriptional regulator for cell proliferation, differentiation,
and survival during hematopoiesis (Oh and Reddy, 1999). The mutated c-Myb site
located at -350 to -333 on the MAT 2A promoter was shown to abolish the induction of
MAT 2A promoter activity and c-Myb nuclear-binding activity mediated by IL-2 and
phorbol ester in lurkat cells (Zeng et aI., 2001). In contrast, overexpression c-Myb in
quiescent lurkat T cells increased MAT 2A promoter activity, suggesting c-Myb plays
an important role in upregulating MAT 2A expression during T cell expansion
(Venturelli et aI., 1990; Furukawa et aI., 1990). Although multiple gene targets
regulated by c-Myb transactivation have been identified in T lymphocytes (Andersson
et aI., 1999), there is little information on genes that are relevant for CD4+ T
lymphocyte survival. Studies have shown that 1 IlM HNE inhibited c-myb mRNA at 1
h whereas 10 IlM HNE inhibited c-Myb expression at 3-6 h in leukemia HL-60 cells
(Barrera et aI., 1996). Similarly, our results showed that c-Myb expression decreased
dose-dependently from 2.5 IlM and were completely blocked at 6 h after treated with
10 IlM HNE (Fig. 31). All together, these results demonstrate that HNE-induced
downregulation of MAT 2A gene expression occurs through a decrease of c-Myb.
This finding suggests that the MAT 2A gene is directly associated with T cell survival
and is an important target gene for c-Myb in the regulation of T cell growth.
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Additionally, studies have shown the c-Myb protein that is bound specifically
to DNA fragments is negatively regulated by phosphorylation of the amino-terminus
with the protein kinase CKII (Oelgeschlager et aI., 1995). This suggests DNA-binding
may be regulated by secondary protein modifications. Others have shown that c-myb
transcription is activated by protein kinase B following IL-2 stimulation and is required
for PKBIPI3K-mediated protection from apoptosis in T cells (Lauder et aI., 2001).
Also it is known that c-Myb activity is required for Akt, a survival factor, during T cell
activation and that the c-Myb gene is regulated only by components of the PI-3K
pathway (Lauder et aI., 2001). Based on our PTCA results, the mechanism of
upregulation of c-Myb might possibly be through multiple pathways and may include
increased redox restoration and kinase phosphorylation.
Both intracellular antioxidant concentrations (GSH and SAMe) and c-Myb have
been shown to be important regulators for cell proliferation and survival in CD4+ T
lymphocytes (German et aI., 1983; Venturelli et aI., 1990). However, fewer studies
have investigated the association of GSHISAMe and c-Myb. Our results are the first to
show that the restoration of endogenous antioxidant concentrations by PTCA
influences the expression of c-Myb in vitro (Fig. 31). As a transcription factor, the
DNA binding activity of c-Myb is suggested to be regulated by a reduction-oxidation
mechanism. Oxidation by diamide of the Myb-proteins in vitro inhibits their
interaction with DNA, whereby the diamide effect is reversible by supplementation
with reducing agents such as DTT (Guehmann et aI., 1992).
Since SAMe and MAT are critical for CD4+ T lymphocytes survival and
proliferation, downregulation effects of HNE on MAT II expression and activity and
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consequent SAMe deficiency may lead to apoptotic T cell death. During apoptosis,
caspase-3 has been demonstrated to cleave vital proteins such as poly (ADP-ribose)
polymerase (PARP) and to amplify upstream caspase signals leading to DNA
fragmentation at the end stage of apoptosis (Liu et aI., 2000). Our previous work
characterized HNE-mediated CD4+ T cell apoptosis by recruiting procaspase-8, an
initiating caspase, to DISC through FaslFasL pathway in the early stage and thereby
activating a series of caspase cascades. In the present study, we demonstrated that
inhibition of SAMe biosynthesis by HNE led to activation of caspase-3. Recently, our
laboratory has shown that cycloleucin, a MAT inhibitor, significantly increases
caspase-3 and -8 cleavages and leads to DNA fragmentation. More importantly, we
demonstrated for the first time that PTCA can attenuate HNE-induced caspase-3
activation (Fig. 31), along with its protection against HNE-induced apoptosis in CD4+
T cells. Other antioxidant such as NAC was also shown to block HNE-induced
caspase-3 activation and DNA fragmentation in Jurkat T cells (Liu et aI., 2000).
Further, pretreatment of Jurkat T cells with anethole dithiolethione (10-50 rnM, 18 h)
restored HNE-induced cytotoxicity (Khanna et aI., 1998). Thus, our results confirmed
findings of others on the protective effect of antioxidants and suggest that PTCA
protects against HNE-induced caspase-3 activation and caspase-3 dependent apoptosis,
possibly through GSH restoration.
In conclusion, we have identified MAT II and SAMe are critical molecular
components required for CD4+ T cell survival, and HNE downregulates MAT II
expression and activity resulting in SAMe depletion. Based on these findings, we
postulate that investigation of the effects of HNE on CD4+ T cell MATII activity,
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SAMe levels, and survival will provide important information concerning mechanisms
of immunosuppression. Additionally, attenuation of HNE-induced apoptotic T cell
death by GSH prodrug (PTCA) provides a potential therapeutic use in treating immune
dysfunction associated with other immnunosuppressive disorders such as HIV/HCV
infection and diabetes.
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CHAPTER V
SUMMARY AND CONCLUSION

The principle hypotheses of the project were that 1) human CD4+ T
lymphocytes (Jurkat) would be susceptible to HNE-induced cytotoxicity but
relatively resistant to MDA, 2) HNE-induced cytotoxicity involves an early
formation of DISC, which is Fas-FasL -dependent pathway and can be detoxified
by restoration of GSH and concomitant activation of Akt kinase, 3) and that
SAMe depletion and MAT II downregulation by HNE might be involved in
HNE-induced cytotoxicity.

Summary of results
1. HNE inhibits Akt activation, enhances FasL expression, and induces
DISC formation with increased binding of FADD leading to caspase-8
activation
2. DISC formation and caspase-8 activation are critical initiating events in
the HNE induced Fas-mediated apoptotic death in CD4+ T lymphocytes.
3. HNE causes dose dependent Akt downregulation and PP2A upregulation,
concomitantly, both are regulated by GSH.
4. HNE causes dose- and time-dependent decreases in intracellular GSH
concentrations.
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5. PTCA, a GSH precursor, attenuates HNE-induced intracellular GSH
depletion and protected against HNE-induced Fas-mediated apoptotic cell
death through Akt and c-FLIPs .
6. BSO, a GSH depleting agent, increases sensitization to lipid peroxidation
and potentiates cytotoxicity by Akt inactivation and dephosphorylation.
7. MAT II and SAMe are critical molecular targets affected by HNE in CD4+ T
lymphocytes.
8. HNE down-regulates MAT II activity and MAT 2A expression resulting in
intracellular SAMe depletion in CD4+ T lymphocytes.
9. A close correlation was established between GSH, cytotoxicity, survival
factor and MAT II activity.
10. HNE down-regulates c-Myb expression, which is a transcription activator
ofMAT2A.
11. PTCA restores intracellular SAMe levels, MAT II activity, upregulates MAT 2A
and c-Myb expression and prevents HNE-induced caspase-3 dependent
apoptotic cell death.

Conclusion
1. A complete signaling pathway on HNE-induced cytotoxicity was
established.
2. A critical threshold level of GSH was found to be associated with HNE
induced cytotoxicity, decreases p-Akt activity, and inhibition of MAT II
activity and PTCA can protect against these.
3. PTCA may be beneficial in the treatment of immunosuppressive disorders
involving CD4+ T cell depletion, such as HIV and HCV infection.

107

REFERENCES
Andersson, K.B., Berge, T., Matre, v., and Gabrielsen, O.S. (1999). Sequence
selectivity of c-Myb in vivo. Resolution of a DNA target specificity
paradox. J BioI Chem. 274: 21986-21994.
Barrera, G., Di Mauro, c., Muraca, R, Ferrero, D., Cavalli, G., Fazio, V.M.,
Paradisi, L. and Dianzani, M.U. (1991). Introduction of differentiation in
human HL-60 cells by 4-hydroxy nonenal, a product of lipid peroxidation.
Exp. Cell Res. 197: 148-152.
Barrera, G., Pizzimenti, S., Serra, A, Ferretti, c., Ffazio, V.M., Saglio, G .. , and
Dianzani, M.U. (1996). 4-hydroxynonenal specifically inhibits c-myb but
does not affect c-fos expressions in HL-60 cells. Biochem Biophys Res
Commun. 227: 589-593.
Bauer, B. and Baier, G. (2001). Protein kinase C and Aktlprotein kinase Bin CD4+
T lymphocytes: new partners in TCR/CD28 signal integration. Mol
Immunoz. 38: 1087-1099.
Benedetti, A, Comporti, M., Fulceri, R, and Esterbauer, H. (1984). Cytotoxic
aldehydesoriginating from the peroxidation of liver microsomal lipids.
Identification of 4,5-dihydroxydecenal. Biochim. Biophys. Acta 792: 172181.
Brunner, T., Wasem, c., Torgler, R, Cima, I., Jakob, S., and Corazza, N. (2003).
Fas (CD951 Apo-l) ligand regulation in T cell homeostasis, cell-mediated
cytotoxicity and immune pathology. Semin. Immunoz. 15: 167-176.
Burgering, B.M. and Coffer, P.J. (1995). Protein kinase B (c-Akt) in
phosphatidylinositol-3-0H kinase signal transduction. Nature 376: 599-602.
Calabrese, V., Scapagnini, G., Latteri, S., Colombrita, c., Ravagna, A, Catalano,
c., Pennisi, G., Calvani, M., and Butterfield, D.A (2002). Long-term
ethanol administration enhances age-dependent modulation of redox state in
different brain regions in the rat: protection by acetyl carnitine. Int. J. Tissue
React. 24: 97-104.
Cambiaggi, c., Dominici, S., Comporti, M., and Pompella A (1997). Modulation of
human T lymphocyte proliferation by 4-hydroxynonenal, the bioactive
product of neutrophil-dependent lipid peroxidation. Life Sci. 61: 777-785.
Cantoni, G.L. (1953). S-adenosylmethionine; a new intermediate formed
enzymatically from L-methionine and adenosinetriphosphate. J. BioI. Chem.
204: 403-416.
Cardone, M.H., Roy, N., Stennicke, H.R, Salvesen, G.S., Franke, T.E, Stanbridge,
E., Frisch, S., and Reed, J.C. (1998). Regulation of cell death protease
caspase-9 by phosphorylation. Science 282: 1318-1321.

108

Cederbaum, A.I. (1989). Role of lipid peroxidation and oxidative stress in alcohol
toxicity. Free Radic. Bioi. Med. 7: 537-539.
Chandra, A.; Srivastava, S.; Petrash, J.M.; Bhatnagar, A.; Srivastava, S.K. (1997).
Modification of aldose reductase by S-nitrosoglutathione. J. Biochern.
36:15801-15809.
Chang, W., (2004). Mechanism of oxidative stress induced cell toxicity. Master
thesis, University of Louisville.
Chen, J., Martin, B. L., and Brautigan, D. L. (1992). Regulation of protein serinethreonine phosphatase type-2A by tyrosine phosphorylation. Science 257,
1261-1264.
Chen, T., Pearce, L.L., Peterson, J., Stoyanoysky, D., and Billiar, T.R (2005).
Glutathione depletion renders rat hepatocytes sensitive to nitric oxide donormediated toxicity. Hepatology. 42: 598-607.
Chen, T.S., Richie, J.P., Jr., and Lang, c.A. (1990). Life span profiles of glutathione
and acetaminophen detoxification. Drug Metab. Dispos. 18: 882-887.
Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, YM. (1995). FADD, a
novel death domain-containing protein, interacts with the death domain of
Fas and initiates apoptosis. Cell 81: 505-512.
Clot, P., Tabone, M., and Albano, E. (1994). Monitoring oxidative damage in
patients with liver cirrhosis and different daily alcohol intake. Gut 35: 16371643.
Cook, RT. (1999). Alcohol abuse, alcoholism, and damage to the immune system-a
review. Alcohol CZin. Exp. Res. 22: 1927-1942.
Corrales, F., Ochoa, P., Rovas, c., Martin-Lomas, M., Mato, J.M., and Pajares,
M.A. (1991). Inhibition of glutathione synthesis in the liver leads to Sadenosyl-L-methionine synthetase reduction. Hepatology. 14: 528-533.
Corrales, F., Gimenez, A., Alvarez, L., Caballeria, J., Pajares, M.A., Andreu, H.,
Pares, A., Mato, J.M. and Rodes, J. (1992). S-Adenosylmethionine treatment
prevents carbon tetrachloride induced S-adenosylmethionine synthetase
inactivation and attenuates liver injury. Hepatology 16: 1022-1027.
Cross, D.A, Alessi, D.R, Cohen, P., Andjelkovich, M., and Hemmings, B.A.
(1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by
protein kinase B. Nature 378: 785-789.
Datta, S.R, Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M.E.
(1997). Akt phosphorylation of BAD couples survival signals to the cellintrinsic death machinery. Cell 91 : 231-241.
De La Rosa, J., LeGros, Jr. H.L., Valentine, M., and Geller, A. (1995).
Chromosomal localization and catalytic properties of the recobinant a
subunit of human lymphocyte methionine adenosyltransferase. J. Bioi.
Chern. 270: 21860-21868.
De La Rosa, J., Geller, A.M., LeGros, Jr. H.L., and Kotb M. (1992). Induction of

interleukin-2 production but not methionine adenosyltransferase activity or
s-adenosylmethionine turnover in Jurkat T cells. Cancer Res. 52: 33613366.
109

del Peso, L., Gonzalez-Garcia, M., Page, c., Herrera, R, and Nunez, G (1997).
Interleukin- 3-induced phosphorylation of BAD through the protein kinase
Akt. Science 278: 687-689.
Droge, W., Pottmeyer-Gerber, c., Schmidt, H. and Nick, S. (1986). Glutathione
augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology
172: 151-156.
Esposito, P., Chirico, G, Montesano Gesualdi, N., Posadas, 1., Ammendola, R,
Russo, T., Cirino, G, and Cimino, P. (2003). Protein kinase B activation by
reactive oxygen species is independent of tyrosine kinase receptor
phosphorylation and requires SRC activity. J Biol Chem. 278: 20828-20834.
Esterbauer, H., Schaur, RJ., and Zollner, H. (1991). Chemistry and biochemistry of
4-hydrdoxynonenal, malonaldehyde, and related aldehydes. Free Radic.
Bioi. Med.ll: 81-128.
Franke, T.P., Yang, S.l., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K.,
Kaplan, D.R, and Tsichlis, P.N. (1995). The protein kinase encoded by the
Aky proto-oncogene is a target of the PDGF-activated phosphatidyllinositol
3-kinase. Cell 81: 727-736.
Friesen, C., Kiess, Y, and Debatin, K.M. (2004). A critical role of glutathione in
determining apoptosis sensitivity and resistance in leukemia cells. Cell
Death Differ. 11: S73-S85.
Fu, X., Chen, T.S., Ray, M.B., Nagasawa, H.T., Williams, W.M. (2004). pAminophenol-induced hepatotoxicity in hamsters: role of glutathione.
J Biochem Mol Toxico1.18: 154-161.
Furukawa, Y., Piwnica-Worms, H., Ernst, TJ., Kanakura, Y., and Griffin, J.D.
(1990). cdc2 gene expression at the G 1 to S transition in human T
lymphocytes. Science. 250: 805-808.
German, D.C., Bloch, c.A., and Kredich, N.M. (1983). Measurements of Sadenosylmethionine and L-homocysteine metabolism in cultured human
lymphoid cells. J. Biol. Chem. 258: 10997-11003.
Gioacchini, A.M., Calonghi, N., Boga, c., Cappadone, c., Masotti, L., Roda, A.
and Traldi P. (1999). Determination of 4-hydroxy-2-nonenal at cellular
levels by means of electrospray mass spectrometry. Rapid Commun. Mass
Spectrom. 13: 1573-1579.
Gjertsen, B.T. and Doskeland, S.O. (1995). Protein phosphorylation in apoptosis.
Biochim Biophys Acta. 1269: 187-199.
Grethe, S. and Pron-Ares, M.I. (2006). p38 MAPK regulates phosphorylation of
Bad via PP2A-dependent suppression of the MEK1I2-ERK1I2 survival
pathway in TNF-alpha induced endothelial apoptosis. Cell Signal. 18: 531540.
Guehmann, S., Vorbrueggen, G., Kalkbrenner, F., and Moelling, K. (1992).
Reduction of a conserved Cys is essential for Myb DNA-binding.
Nucleic Acids Res. 20: 2279-2286.
Halvorsen, E.M., Dennis, J., Keeney, P., Sturgill, T.W., Tuttle, J.B., and Bennett,
J.B. Jr. (2002). Methylpyridinium (MPP(+))- and nerve growth factor-

110

induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y
neuroblastoma cells. Brain Res. 952: 98-110.
Hamilos, D.L. and Wedner, H.J. (1985). The role of glutathione in lymphocyte
activation. 1. Comparison of inhibitory effects of buthionine sulfoximine and
2-cyclohexene-l-one by nuclear size transformation. J. Immunol135: 27402747.
Hausler, P., Papoff, G., Eramo, A., Reif, K. Cantrell, D.A., and Ruberti, G. (1998).
Protection of CD95-mediated apoptosis by activation of
phosphatidylinositide 3-kinase and protein kinase B. Eur J Immunol. 28: 5769.
Honchel, R, Ray, M.B., Marsano, L., Cohen, D., Lee, E., Shedlofsky, S., and
McClain, C.J. (1992). Tumor necrosis factor in alcohol enhanced endotoxin
liver injury. Alcohol. Clin. Exp. Res. 16: 665-669.
Ikeda, T, Nakata, Y, Kimura, F., Sato, K., Anderson, K., Motoyoshi, K., Sport, M.,
and Kufe, D. (2004). Induction of redox imbalance and apoptosis in
multiple myeloma cells by the novel triterpenoid 2-cyano-3, 12-dioxoolean1,9-dien-28-oic acid. Mol Cancer Ther. 3: 39-45.
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V.,
Bodmer, J.L., Schroter, M., Bums, K., Mattmann, C., Rimoldi, D.,
French, L.E., and Tschopp, J. (1997). Inhibition of death receptor signals by
cellular FLIP. Nature 388: 190-195.
Ito, K., Miwa, N., Hagiwara, K., Yano, T., Shimizu-Saito, K., Goseki, N., Iwai, T.,
and Horikawa, S. (1999). Regulation of methionine adenosyltransferase
activity by the glutathione level in rat liver during ischemia-reperfusion.
Surg Today. 29: 1053-1058.
Ivaska, J., Nissinen, L., Immonen, N., Eriksson, J.E., Kahari, V.M. and Heino, J.
(2002). Integrin alpha 2 beta 1 promotes activation of protein phosphatase
2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol
Cell Bioi. 22: 1352-1359.
Jamnicki-Abegg, M., Weihrauch, D., Pagel, P.S., Kersten, J.R, Bosnjak, Z.J.,
Warltier, D.C., and Bienengraeber, M.W. (2005). Isoflurane inhibits cardiac
myocyte apoptosis during oxidative and inflammatory stress by activating
Akt and enhancing Bcl-2 expression. Anesthesiology. 103: 1006-1014.
Jiang, S., Wu, M.W., Sternberg, P., and Jones, D.P. (2000). Fas mediates apoptosis
and oxidant-induced cell death in cultured hRPE cells. Invest Ophthalmol
Vis Sci. 41: 645-655.
Kajimoto, G.S., Umayahara, Y., Kaneto, H., Watada, H., Kuroda, A., Kawamori,
D., Yasuda, T., Matsuhisa, M., Yamasaki, Y., and Hori, M. (2002).
Probucol preserves pancreatic beta-cell function through reduction of
oxidati ve stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57: 1-10.
Kalinich, J.F., Ramakrishnan, R, McClain, D.E., and Ramakrishnan, N. (1999). 4Hydroxynonenal, an end-product of lipid peroxidation, induces apoptosis in
human leukemic T- and B-celllines. Free Radic. Res. 33: 349-358.
Kasibhatla et aI., Genestier, L., and Green, D.R (1999). Regulation of fas-ligand
expression during activation-induced cell death in T lymphocytes via
nuclear factor kappaB. J Bioi Chem. 274: 987-992.

111

Khanna, S., Sen, e.K, Roy, S., Christen, M.a., and Packer, L. (1998). Protective
effects of anethole dithiolethione against oxidative stress-induced
cytotoxicity in human Jurkat T cells. Biochem. Pharmacol. 56: 61-69.
Kim, S.J., Kim, R.G., Lim, H.W., Park, E.H., and Lim, CJ. (2005). Up-regulation
of glutathione biosynthesis in NIH3T3 cells transformed with the ETV6NTRK3 gene fusion. Mol Cells. 19: 131-136.
Koch, O.R., Galeotti, T., Bartoli, G.M., and Boveris, A. (1991). Alcohol-induced
oxidative stress in rat liver. Xenobiotica 21: 1077-1084.
Kops, GJ. and Burgering, B.M. (1999). Forkhead transcription factors: new
insights into protein kinase B (c-akt) signaling. J. Mol. Med. 77: 656-665.
Kotb, M. and Kredich, N. (1985). S-adenosylmethionine synthetase from human
lymphocytes-purification and characterization. J. Bio!. Chem. 260: 39233930.
Kotb, M. and Geller, A. (1993). Methionine adenosyltransferase: structure and
function. Pharmac. Ther. 59: 125-143.
Krueger, A., Schmitz, I., Baumann, S., Krammer, P.H., and Kirchhoff, S. (200Ia).
Cellular FLICE-inhibitory protein splice variants inhibit different steps of
caspase-8 activation at the CD95 death-inducing signaling complex. J. Bioi.
Chem. 276: 20633-20640.
Krueger, A., Baumann, S., Krammer, P.R., and Kirchhoff, S. (2001). FLICEinhibitory proteins: regulators of death receptor-mediated apoptosis. Mol.
Cell. Bio!. 21: 8247-8254.
Kruman, I., Bruce-Keller, AJ., Bredesen, D., Waeg, G., and Mattson, M.P. (1997).
Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal
apoptosis. J. Neurosci. 17: 5089-5100.
Lang, e.A., Mills, B.J., Mastropaolo, W., and Liu, M.e. (2000). Blood glutathione
decreases in chronic diseases. J Lab. CZin. Med.135: 402-405.
Lauder, A., Castellanos, A. and Weston K. (2001). c-Myb transcription is activated
by protein kinase B (PKB) following interleukin 2 stimulation of T cells and
is required for PKB-mediated protection from apoptosis. Mol Cell Bioi. 21:
5797-5805.
LeGros, Jr. H.L., Geller, A., and Kotb, M. (1997). Differential regulation of
methionine adenosyltransferase in superantigen and mitogen stimulated
human T lymphocytes. J. Biol. Chem. 272: 16040-16047.
Liu, W., Kato, M., Andwaral, A., and Akhand I. (2000). 4-hydroxynonenal induces
a cellular redox status-related activation of the caspase cascade for apoptotic
cell death. 1. Cell. Sci. 113: 635-641.
Liu, W., Akhand, A.A., Takeda, K, Kawamoto, Y., Itoigawa, M., Kato, M.,
Suzuki, H., Ishikawa, N, and Nakashima, I. (2003). Protein phosphatase 2Alinked and -unlinked caspase-dependent pathways for downregulation of
Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ. 10: 772-781.
Livak, KJ. and Schmittgen, T.D. (2001). Analysis of relative gene expression data
MC
using real-time quantitative PCR and 2- r method. Methods 25: 402-408.
Lu, S.e. (2000). S-adenosylmethionine. Int. Jour. Biochem. Cell Bio!. 32: 391-395.

112

Lu, S.c. and Mato, J.M. (2005). Role of methionine adenosyltransferase and Sadenosylmethionine in alcohol-associated liver cancer. Alcohol. 35: 227234.
MacGregor, RR (1986). Alcohol and immune defense. lAMA 256: 1474-1479.
Marconi, A., Atzel, P. Panza, c., Fila, c., Tiberio, R, Truzzi, F. Wachter, T.,
Leverkus, M., and Pincelli, C. (2004). FLICE/caspase-8 activation triggers
anoikis induced by beta1-integrin blockade in human keratinocytes. 1 Cell
Sci. 117: 5815-5823.
Martinez-Lorenzo, MJ., Alava, M.A., Gamen, S., Kim, KJ., Chuntharapai, A.,
Pineiro, A., Naval, J., and Anel, A. (1998). Involvement of AP02
ligand/TRAIL in activation-induced death of Jurkat and human peripheral
blood T cells. Eur. 1. Immunol. 28: 2714-2725.
Mato, J.M., Avila, M.A., Ortiz, P., and Pajares, M.A. (1997). SAdenosylmethionine synthesis: molecular mechanisms and clinical
implications. Pharmacol. Ther. 73: 265-280.
Mato, J.M., Corrales, FJ., Lu, S.c., and Avila, M.A. (2002). SAdenosylmethionine: a control switch that regulates liver function. FASEB
l. 16: 15-26.
McClowskey, T.W., Chavan, S., Lakshmi Tamma, S.M., and Pahwa, S. (1998).
Comparison of seven quantitative assays to assess lymphocytic cell death
during HIV infection: measurement of induced apoptosis in anti-Fas treated
Jurkat cells and spontaneous apoptosis in peripheral blood mononuclear
cells from children infected with HIV. AIDS Res. Hum. Retroviruses 14:
1413-1422.
Medema, J.P., Scaffidi, c., Kischkel, F.C., Shevchenko, A., Mann, M., Krammer,
P.H., and Peter, M.E. (1997). FLICE is activated by association with the
CD95 death-inducing signaling complex (DISC). EMBO 1. 16: 2794-2804.
Meister, A, Metabolism and function of glutathione. In: Dolphin, D., Poulson R
and Avramovic, O. (Eds.) (1989). Glutathione: Chemical, Biochemical and
Medical Aspects. John Wiley, New York. 367-474.
Merali, S., Vargas, D., Franklin, M., and Clarkson, A.B.Jr. (2000). SAdenosylmethionine and Pneumocystis carinii. 1. Biol. Chem. 275: 1495814963.
Michiels, C. and Remacle, J. (1991). Cytotoxicity of linoleic acid peroxide,
malondialdehyde and 4-hydroxynonenal towards human fibroblasts.
Toxicology. 66: 225-234.
Minotti, G., Di Gennaro, M., D' Ugo, D., and Granone, P. (1991). Possible source
of iron for lipid peroxidation. Free Radical. Res. Commun. 1: 99-106.
Murata, H., Ihara, Y., Nakamura, H., Yodoi, J., Sumikawa, K., and Kondo, T.
(2003). Glutaredoxin exerts an antiapoptotic effect by regulating the redox
state of Akt. 1 Bioi Chem. 278: 50226-50233.
Nagasawa, H.T., Goon, DJ., Muldoon, W.P., and Zera, RT. (1984). 2-Substituted
thiazolidine-4(R)-carboxylic acids as prodrogs of I-cysteine. Protection of
mice against acetaminophen hepatoxicity. l. Med. Chern. 27: 591-596.
Nakamura, H., Masutani, H., and Yodoi, J. (2002). Redox imbalance and its control
in HIV infection. Antioxid. Redox. Signal. 4: 455-464.
113

Navas, S., Martin, 1., Ouiroga, 1.A, Castillo, 1., and Carreno, V. (1998). Genetic
diversity and tissue compartmentalization of the hepatitis C virus genome in
blood mononuclear cells, liver, and serum from chronic hepatitis C patients.
J Virol. 72: 1640-1646.
Noshita, N., Lewen, A, Sugawara, T., and Chan, P.H. (2001). Evidence of
phosphorylation of Akt and neuronal survival after transient focal cerebral
ischemia in mice. J. Cereb. Blood Flow Metab. 21: 1442-1450.
Oelgeschlager, M., Krieg, J., Luscher-Firzlaff, 1.M., and Luscher, B. (1995). Casein
kinase II phosphorylation site mutations in c-Myb affect DNA binding and
transcriptional cooperativity with NF-M. Mol Cell BioI. 15: 5966-5974.
Oh, LH. and Reddy, E.P. (1999). The myb gene family in cell growth,
differentiation and apoptosis. Oncogene. 18: 3017-3033.
Ouyang, Y.B., Tan, Y., Comb, M., Liu, C.L., Martone, M.E., Siesj6, B.K, and Hu,
B.R. (1999). Survival- and death-promoting events after transient cerebral
ischemia: phosphorylation of Akt, release of cytochrome c and activation of
caspase-like proteases. J. Cereb. Blood Flow Metab. 19: 1126-1135.
Panayiotidis, M.L, Stabler, S.P., Ahmad, A, LeGros, L.HJr., Hernandez-Saavedra,
D., Schneider, B.K, Allen, R.H., Vasiliou, V., McCord, J.M., Kotb, M, and
White, C.W. (2006). Activation of a novel isoform of methionine adenosyl
transferase 2A and increased S-adenosylmethionine turnover in lung
epithelial cells exposed to hyperoxia. Free Radic Bioi Med. 40: 348-358.
Peter, M.E. and Krammer, P.H. (2003). The CD95 (APO-l/Fas) DISC and beyond.
Cell Death Differ. 10: 26-35.
Peterson, J.D., Herzenberg, L.A, Vasquez, K, and Waltenbaugh, C. (1998).
Glutathione levels in antigen-presenting cells modulate Th 1 versus Th2
response patterns. Proc. Natl. Acad. Sci. U.S.A. 95: 3071-3076.
Raju, P.A, Herzenberg, L.A, and Roederer, M. (1994). Glutathione precursor and
antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate
compared in in vitro studies of HIV replication. AIDS Res Hum
Retroviruses. 10: 961-967.
Resjo, S., Goransson, 0., Hamdahl, L., Zolnierowicz, S., Manganiello, V., and
Degerman, E. (2002). Protein phosphatase 2A is the main phosphatase
involved in the regulation of protein kinase B in rat adipocytes. Cell Signal.
14: 231-238.
Richie, J.P. Jr, and Lang, C.A (1987). The determination of glutathione, cyst(e)ine,
and other thiols and disulfides in biological samples using high performance
liquid chromatography with dual electrochemical detection. Anal. Biochem.
163: 9-15.
Rigamonti, c., Mottaran, E., Reale, E., Rolla, R., Cipriani, V., Capelli, F.,
Boldorini, R., Vidali, M., Sartori, M., and Albano, E. (2003). Moderate
alcohol consumption increase oxidative stress in patients with chronic
hepatitis C. Hepatology 38: 42-49.
Romero, FJ., Bosch-Morell, F., Romero, M.J., Jareno, E.J., Romero, B., Marin, N.,
and Roma, J. (1998). Lipid peroxidation products and antioxidants in human
disease. Environ. Health Perspect. 106: S1229-S1234.

114

Salinas, M., Diaz, R, Abraham, N., Ruiz, De Galarreta, e.M., and Cuadrado, A.
(2003). Nerve growth factor protects against 6-hydroxydopamine-induced
oxidative stress by increasing expression of heme oxygenase-l in a
phosphatidylinositol 3 kinase-dependent manner. J. Bioi. Chem. 278:
13898-13904.
Santoro, M.P., Annand, RR., Robertson, M.M., Peng, YW., Mankovich, J.A.,
Hackett, M.e., Ghayur, T., Walter, G, Wong, W.W., and Giegel, D.A.
(1998). Regulation of protein phosphatase 2A activity by caspase-3 during
apoptosis. J Bioi Chem. 273: 13119-13128.
Schraven, B. and Peter, M.E. (1995). APO-l(CD95)-mediated apoptosis in Jurkat
cells does not involve src kinases or CD45. FEBS Lett. 368: 491-494.
Sen, e.K. (1997). Nutritional biochemistry of cellular glutathione. J. Nutr. Biochem.
8: 660-672.
Sen, e.K. (1998). Redox signaling and the emerging therapeutic potential of thiol
antioxidants. Biochem. Pharmacol. 55: 1747-1758.
Serafini, M. (2000). Dietary vitamin E and T cell-mediated function in the elderly:
effectiveness and mechanism of action. Review. Int. J. Dev. Neurosci. 18:
401-410.
Seyfried, J., Soldner, F., Schulz, J.B., Klockgether, T., Kovar, K.A., and Wullner,
U. (1999). Differential effects of L-buthionine sulfoximine and ethacrynic
acid on glutathione levels and mitochondrial function in PC12 cells.
Neurosci Lett. 264: 1-4.
Shan, X.Q., Aw, T.Y., and Jones, D.P. (1990). Glutathione-dependent protection
against oxidative injury. Pharmacol. Ther. 47: 61-71.
Shaw, M., Cohen, P., and Alessi, D.R (1998). The activation of protein kinase B by
H 20 2 or heat shock is mediated by phosphoinositide 3-kinase and not by
mitogen-activated protein kinase-activated protein kinase-2. Biochem J.
336: 241-246.
Shellito, J.E. and Olariu, R. (1998). Alcohol decreases T-Iymphocyte migration into
lung tissue in response to Pneumocystis carinii and depletes T-Iymphocyte
numbers in the spleens of mice. Alcohol CZin. Exp. Res. 22: 658-663.
Shirota, P.N., DeMaster, E.G, Shoeman, D.W., and Nagasawa, H.T. (2002).
Acetaminophen-induced suppression of hepatic AdoMet synthetase activity
is attenuated by prodrugs of L-cysteine. Toxicol. Lett. 132: 1-8.
Soderdahl, T., Enoksson, M., Lundberg, M., Holmgren, A., Ottersen, O.P., Orrenius,
S., Bolcsfoldi, G, and Cotgreave, LA. (2003). Visualization of the
compartmentalization of glutathione and protein-glutathione mixed
disulfides in cultured cells. FASEB J. 17: 124-126.
Smith, P.E. and Palmer, D.L. (1976). Alcoholism, infection and altered host
defenses: a review of clinical and experimental observations. J. Chronic.
Dis. 29: 35-49.

Song, H. (1994). Mouse and rat differences in p-aminophenol-induced liver and
kidney toxicities. Ph.D. dissertation, University of Louisville.
Spitz, D.R, Sullivan, SJ., Malcom, RR, and Roberts, RJ. (1991). Glutathione

115

dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free
Radic BioI Med. 11: 415-423.
Srinivasan, c., Williams, W.M., Nagasawa H.T. and Chen, T.S. (2001). Effects of
2(RS)-n-propylthiazolidine-4(R)-carboxylic acid on extrahepatic sulfhydryl
levels in mice treated with acetaminophen. Biochern. Pharm. 61: 925-931.
Suhara, T., Mano, T., Oliveira, B.E., and Walsh, K (2001). Phosphatidylinositol3kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated
apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res. 89:
13-19.
Suhara, T., Kim, H.S., Kirshenbaum, L.A., and Walsh, K (2002). Suppression of
Akt signaling induces Fas ligand expression: involvement of caspase and
Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell BioI.
22: 680-691.
Suzuki, T., Fukuo, K, Suhara, T., Yasuda, 0., Sato, N., Takemura, Y., Tsubakimoto,
M., and Ogihara, T. (2003). Eicosapentaenoic acid protects endothelial cells
against anoikis through restoration of cFLIP. Hypertension. 42: 342-348.
Suhara, T., Fukuo, K, Yasuda, 0., Tsubakimoto, M., Takemura, Y., Kawamoto, H.,
Yokoi, T., Mogi, M., Kaimoto, T, and Ogihara, T. (2004). Homocysteine
enhances endothelial apoptosis via upregulation of Fas-mediated pathways.
Hypertension. 43: 1208-1213.
Tibbetts, M.D., Zheng, L., and Lenardo, M.J. (2003). The death effector domain
protein family: regulators of cellular homeostasis. Nat. Irnrnunol. 4: 404409.
Uchida, K (2003). 4-Hydroxy-2-nonenal: a product and mediator of oxidative
stress. Review. Prog. Lipid Res. 42: 318-343.
Uriarte, S.M., Joshi-Barve, S., Song, Z., Sahoo, R, Gobejishvili, L., Jala, V.R,
Haribabu, B., McClain, c., and Barve, S. (2005). Akt inhibition upregulates
FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in
Jurkat T lymphocytes. Cell Death Differ. 12: 233-242.
Van Kanegan, MJ., Adams, D.G., Wadzinski, B.E., and Strack, S. (2005). Distinct
protein phosphatase 2A heterotrimers modulate growth factor signaling to
extracellular signal-regulated kinases and Akt. J BioI Chern. 280: 3602936036.
Venturelli, D., Travali, S., and Calasbretta, B. (1990). Inhibition of T-cell
proliferation by a MYB antisense oligomer is accompanied by selective
down-regulation of DNA polymerase alpha expression. Proc Natl Acad Sci
USA. 87: 5963-5967.
Wang, J.F. and Spitzer, J.J. (1997). Alcohol-induced thymocyte apoptosis is
accompanied by impaired mitochondrial function. Alcohol 14: 99-105.
Yellaturu, C.R, Bhanoori, M., Neeli, 1., and Rao, G.N. (2002). N-Ethylmaleimide
inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation
via activation of protein phosphatase 2A. J BioI Chern. 277: 40148-40155.
Yu,

c., Rahmani, M., Almenara, 1., Sausville, E.A., Dent, P., and Grant, S. (2004).
Induction of apoptosis in human leukemia cells by the tyrosine kinase
inhibitor adaphostin proceeds through a RAF-1IMEKlERK- and AKT116

dependent process. Oncogene 23: 1364-1376.
Zeng, Z., Yang, H., Huang, Z., Chen, C, Wang, J., and Lu, S. (2001). The role of cMyb in the up-regulation of methionine adenosyltransferase 2A expression
in activated lurkat cells. Biochem. J. 353: 163-168.

117

LIST OF ABBREVIATIONS
ADT, anethole dithiolethione
AICD, activation-induced cell death
APAP, acetaminophen
ASKl, apoptosis signal-regulating kinase 1
BSO, buthionine sulfoximine
Cys, L-cysteine
DISC, death-inducing signaling complex
DEM, diethyl maleate
DTT, dithiolthreitol
EPA, eicosapentaenoic acid
ECL, enhanced chemiluminescence
FADD, Fas-associated death domain
FasL, Fas ligand
FLICE, FADD-like interleukin 1 l3-converting enzyme
FLIP, FLICE inhibitory protein
GSK3, glycogen synthase kinase 3
GSH, glutathione
GSSG, glutathione disulfide
HIV, human immunodeficiency virus
HO-l, heme oxygenase 1
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HNE, 4-hydroxynonenal
HPLC, high performance liquid chromatography
H 20 2, hydrogen peroxide
LDH, lactate dehydrogenase
MAT, methionine adenosyltransferase
MDA, malondialdehyde
MP A, monochloroacetic acid
MPP+, methylpyridinium
NF"B, nuclear factor-kappa B
NAC, N-acetyl-cysteine
OTC, L-2-0xothiazolidine 4-carboxylate
PAP, para-aminophenol
PBS, phosphate buffered saline
PD K 1, phosphoinositide-dependent kinase-l
PHA, phytohemagglutinin
PMA, phorbol 12-myristate 13-acetate
PMSF, phenylmethylsulphonylfluoride
PP2A, protein phosphatase-2A
PTCA, 2(RS)-n-Propylthiazolidine-4(R)-carboxylic acid
SAH, S-adenosylhomocysteine
SAMe, S-Adenosyl-methionine
SDS-PAGE, sodium dodecyl solfate-polyacrylamide gel electrophoresis
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